Skip to Main Content
CWRU Links


2015 Member Publications

This is a list of publications authored by Cancer Center members.  Publications are listed in alphabetical order by first author. 

Abbas R, McColl KS, Kresak A, Yang M, Chen Y, Fu P, Wildey G, Dowlati A. PIAS3 expression in squamous cell lung cancer is low and predicts overall survival. Cancer Med. 2015 Mar;4(3):325-32. doi: 10.1002/cam4.372. Epub 2015 Jan 9. PMID:25573684 | PMCID:PMC4380958

Abboud SE, Wolansky LJ, Manjila SV, Lo SS, Arafah BM, Selman WR, Couce ME, Rogers LR. Histologically Proven Radiation-Induced Brainstem Glioma 93 Months After External Beam Radiotherapy for Pituitary Macroadenoma: Radiation Treatment Dose and Volume Correlation. J Neuroimaging. 2015 Jul;25(4):674-6. doi: 10.1111/jon.12181. Epub 2014 Oct 27. PMID:25345677

Abola MV, Thompson CL, Chen Z, Chak A, Berger NA, Kirwan JP, Li L. Serum levels of retinol-binding protein 4 and risk of colon adenoma. Endocr Relat Cancer. 2015 Apr;22(2):L1-4. doi: 10.1530/ERC-14-0429. No abstract available. PMID:25712946 | PMCID:PMC4342782

Abu-Khalaf MM, Baumgart MA, Gettinger SN, Doddamane I, Tuck DP, Hou S, Chen N, Sullivan C, Lezon-Geyda K, Zelterman D, Hatzis C, Deshpande H, Digiovanna MP, Azodi M, Schwartz PE, Harris LN. Phase 1b study of the mammalian target of rapamycin inhibitor sirolimus in combination with nanoparticle albumin-bound paclitaxel in patients with advanced solid tumors. Cancer. 2015 Jun 1;121(11):1817-26. doi: 10.1002/cncr.29254. Epub 2015 Feb 3. PMID:25649370

Adorno-Cruz V, Kibria G, Liu X, Doherty M, Junk DJ, Guan D, Hubert C, Venere M, Mulkearns-Hubert E, Sinyuk M, Alvarado A, Caplan AI, Rich J, Gerson SL, Lathia J, Liu H. Cancer stem cells: targeting the roots of cancer, seeds of metastasis, and sources of therapy resistance. Cancer Res. 2015 Mar 15;75(6):924-9. doi: 10.1158/0008-5472.CAN-14-3225. Epub 2015 Jan 20. PMID:25604264 | PMCID:PMC4359955

Afable M, Caimi PF, Hosing C, de Lima M, Khouri I, William BM, Nieto Y, Cooper BW, Anderlini P, Gerson SL, Lazarus HM, Champlin R, Popat U. Hematopoietic Progenitor Cell Harvesting Is Feasible after Treatment with Brentuximab Vedotin in CD30(+) Lymphoma Patients Who Received Multiple Prior Lines of Treatment. Biol Blood Marrow Transplant. 2015 Aug;21(8):1529-31. doi: 10.1016/j.bbmt.2015.04.022. Epub 2015 Apr 30. PMID:25937397

Ahluwalia MS, Rich JN. Growth Factor Receptor Fusions Predict Therapeutic Sensitivity. Clin Cancer Res. 2015 Jul 15;21(14):3105-7. doi: 10.1158/1078-0432.CCR-15-0458. Epub 2015 May 20. PMID:25995339

Ahluwalia MS, Xie H, Dahiya S, Hashemi-Sadraei N, Schiff D, Fisher PG, Chamberlain MC, Pannullo S, Newton HB, Brewer C, Wood L, Prayson R, Elson P, Peereboom DM. Efficacy and patient-reported outcomes with dose-intense temozolomide in patients with newly diagnosed pure and mixed anaplastic oligodendroglioma: a phase II multicenter study. J Neurooncol. 2015 Mar;122(1):111-9. doi: 10.1007/s11060-014-1684-y. Epub 2014 Dec 23. PMID:25534576

Ai J, Advani A. Current status of antibody therapy in ALL. Br J Haematol. 2015 Feb;168(4):471-80. doi: 10.1111/bjh.13205. Epub 2014 Nov 10. Review. PMID:25382151

Ai J, Visconte V, Tabarroki A, Hasrouni E, Hamilton BK, Mukherjee S, Kalaycio M, Sobecks R, Advani AS, Sekeres MA, Shetty S, Tiu RV. Non-t(6;9) and Non-Inv(3) Balanced Chromosomal Rearrangements Are Associated With Poor Survival Outcomes in Myelodysplastic Syndromes. Clin Lymphoma Myeloma Leuk. 2015 Aug;15(8):489-95. doi: 10.1016/j.clml.2015.03.017. Epub 2015 Apr 2. PMID:25977195

Aktas A, Walsh D, Kirkova J. The psychometric properties of cancer multisymptom assessment instruments: a clinical review. Support Care Cancer. 2015 Jul;23(7):2189-202. doi: 10.1007/s00520-015-2732-7. Epub 2015 Apr 19. PMID:25894883

Al-Issa K, Visconte V, Rogers HJ, Dembla V, Lichtin AE, Tiu RV. Cyclosporine dependent pure red cell aplasia: a case presentation. Blood Cells Mol Dis. 2015 Mar;54(3):281-3. doi: 10.1016/j.bcmd.2014.11.013. Epub 2014 Nov 25. No abstract available. PMID:25488615

Ali S, Veltri R, Epstein JI, Christudass C, Madabhushi A. Selective invocation of shape priors for deformable segmentation and morphologic classification of prostate cancer tissue microarrays. Comput Med Imaging Graph. 2015 Apr;41:3-13. doi: 10.1016/j.compmedimag.2014.11.001. Epub 2014 Nov 12. PMID:25466771 | PMCID:PMC4346384

Ammori J, Hamzeh K, Graor H, Kim J. Requirement of Innate Immunity in Tumor-Bearing Mice Cured by Adoptive Immunotherapy Using Tumor-Draining Lymph Nodes. J Immunol Res. 2015;2015:170852. doi: 10.1155/2015/170852. Epub 2015 Jun 10. PMID:26090481 | PMCID:PMC4431318

Arem H, Yu K, Xiong X, Moy K, Freedman ND, Mayne ST, Albanes D, Arslan AA, Austin M, Bamlet WR, Beane-Freeman L, Bracci P, Canzian F, Cotterchio M, Duell EJ, Gallinger S, Giles GG, Goggins M, Goodman PJ, Hartge P, Hassan M, Helzlsouer K, et al. Vitamin d metabolic pathway genes and pancreatic cancer risk. PLoS One. 2015;10(3):e0117574. doi: 10.1371/journal.pone.0117574. PMID:25799011 | PMCID:PMC4370655

Awan M, Liu S, Sahgal A, Das S, Chao ST, Chang EL, Knisely JP, Redmond K, Sohn JW, Machtay M, Sloan AE, Mansur DB, Rogers LR, Lo SS. Extra-CNS metastasis from glioblastoma: a rare clinical entity. Expert Rev Anticancer Ther. 2015 May;15(5):545-52. doi: 10.1586/14737140.2015.1028374. PMID:25907706

Bachanova V, Burns LJ, Wang T, Carreras J, Gale RP, Wiernik PH, Ballen KK, Wirk B, Munker R, Rizzieri DA, Chen YB, Gibson J, Akpek G, Costa LJ, Kamble RT, Aljurf MD, Hsu JW, Cairo MS, Schouten HC, Bacher U, Savani BN, Wingard JR, et al. Alternative donors extend transplantation for patients with lymphoma who lack an HLA matched donor. Bone Marrow Transplant. 2015 Feb;50(2):197-203. doi: 10.1038/bmt.2014.259. Epub 2014 Nov 17. PMID:25402415 | PMCID:PMC4336786

Badve C, Sloan AE. Modeling the growth dynamics of glioblastoma using magnetic resonance imaging. Neuro Oncol. 2015 Jul 12. doi:pii: nov120. [Epub ahead of print] No abstract available. PMID:26170260

Bailey SD, Zhang X, Desai K, Aid M, Corradin O, Cowper-Sal Lari R, Akhtar-Zaidi B, Scacheri PC, Haibe-Kains B, Lupien M. ZNF143 provides sequence specificity to secure chromatin interactions at gene promoters. Nat Commun. 2015 Feb 3;2:6186. doi: 10.1038/ncomms7186. PMID:25645053

Balasubramanian BA, Cohen DJ, Davis MM, Gunn R, Dickinson LM, Miller WL, Crabtree BF, Stange KC. Learning Evaluation: blending quality improvement and implementation research methods to study healthcare innovations. Implement Sci. 2015 Mar 10;10(1):31. doi: 10.1186/s13012-015-0219-z. PMID:25889831 | PMCID:PMC4357215

Barzi A, Sadeghi S, Kattan MW, Meropol NJ. Comparative effectiveness of screening strategies for Lynch syndrome. J Natl Cancer Inst. 2015 Mar 20;107(4). doi:pii: djv005.  10.1093/jnci/djv005. Print 2015 Apr. PMID:25794514

Basavanhally A, Viswanath S, Madabhushi A. Predicting classifier performance with limited training data: applications to computer-aided diagnosis in breast and prostate cancer. PLoS One. 2015;10(5):e0117900. doi: 10.1371/journal.pone.0117900. PMID:25993029 | PMCID:PMC4436385

Bejanyan N, Weisdorf DJ, Logan BR, Wang HL, Devine SM, de Lima M, Bunjes DW, Zhang MJ. Survival of patients with acute myeloid leukemia relapsing after allogeneic hematopoietic cell transplantation: a center for international blood and marrow transplant research study. Biol Blood Marrow Transplant. 2015 Mar;21(3):454-9. doi: 10.1016/j.bbmt.2014.11.007. Epub 2014 Nov 15. PMID:25460355 | PMCID:PMC4329076

Berger NA. A time to stop, a time to start: high-dose chemotherapy in overweight and obese patients. Bone Marrow Transplant. 2015 Mar 2. doi: 10.1038/bmt.2015.26. [Epub ahead of print] No abstract available. PMID:25730189

Berney DM, Algaba F, Amin M, Delahunt B, Comp̩rat E, Epstein JI, Humphrey P, Idrees M, Lopez-Beltran A, Magi-Galluzzi C, Mikuz G, Montironi R, Oliva E, Srigley J, Reuter VE, Trpkov K, Ulbright TM, Varma M, Verrill C, Young RH, Zhou M, Egevad L. Handling and reporting of orchidectomy specimens with testicular cancer: areas of consensus and variation among 25 experts and 225 European pathologists. Histopathology. 2015 Sep;67(3):313-24. doi: 10.1111/his.12657. Epub 2015 Mar 17. PMID:25619976

Bicer F, Altuntas CZ, Izgi K, Ozer A, Kavran M, Tuohy VK, Daneshgari F. Chronic pelvic allodynia is mediated by CCL2 through mast cells in an experimental autoimmune cystitis model. Am J Physiol Renal Physiol. 2015. 15;308(2):F103-13.

Biswas T, Walker P, Podder T, Efird JT. Effect of Race and Insurance on the Outcome of Stage I Non-small Cell Lung Cancer. Anticancer Res. 2015 Jul;35(7):4243-9. PMID:26124385

Blume-Jensen P, Berman DM, Rimm DL, Shipitsin M, Putzi M, Nifong TP, Small C, Choudhury S, Capela T, Coupal L, Ernst C, Hurley A, Kaprelyants A, Chang H, Giladi E, Nardone J, Dunyak J, Loda M, Klein EA, Magi-Galluzzi C, Latour M, Epstein JI, et al. Development and Clinical Validation of an In Situ Biopsy-Based Multimarker Assay for Risk Stratification in Prostate Cancer. Clin Cancer Res. 2015 Mar 2. [Epub ahead of print] PMID:25733599

Blume-Jensen P, Berman DM, Rimm DL, Shipitsin M, Putzi M, Nifong TP, Small C, Choudhury S, Capela T, Coupal L, Ernst C, Hurley A, Kaprelyants A, Chang H, Giladi E, Nardone J, Dunyak J, Loda M, Klein EA, Magi-Galluzzi C, Latour M, Epstein JI, et al. Development and clinical validation of an in situ biopsy-based multimarker assay for risk stratification in prostate cancer. Clin Cancer Res. 2015 Jun 1;21(11):2591-600. doi: 10.1158/1078-0432.CCR-14-2603. Epub 2015 Mar 2. PMID:25733599

Blume-Jensen P, Berman DM, Rimm DL, Shipitsin M, Putzi M, Nifong TP, Small C, Choudhury S, Capela T, Coupal L, Ernst C, Hurley A, Kaprelyants A, Chang H, Giladi E, Nardone J, Dunyak J, Loda M, Klein EA, Magi-Galluzzi C, Latour M, Epstein JI, et al. Development and clinical validation of an in situ biopsy-based multimarker assay for risk stratification in prostate cancer. Clin Cancer Res. 2015 Jun 1;21(11):2591-600. doi: 10.1158/1078-0432.CCR-14-2603. Epub 2015 Mar 2. PMID:25733599

Brockman JA, Alanee S, Vickers AJ, Scardino PT, Wood DP, Kibel AS, Lin DW, Bianco FJ Jr, Rabah DM, Klein EA, Ciezki JP, Gao T, Kattan MW, Stephenson AJ. Nomogram Predicting Prostate Cancer-specific Mortality for Men with Biochemical Recurrence After Radical Prostatectomy. Eur Urol. 2015 Jun;67(6):1160-7. doi: 10.1016/j.eururo.2014.09.019. Epub 2014 Oct 6. PMID:25301759

Brockman JA, Alanee S, Vickers AJ, Scardino PT, Wood DP, Kibel AS, Lin DW, Bianco FJ Jr, Rabah DM, Klein EA, Ciezki JP, Gao T, Kattan MW, Stephenson AJ. Nomogram Predicting Prostate Cancer-specific Mortality for Men with Biochemical Recurrence After Radical Prostatectomy. Eur Urol. 2015 Jun;67(6):1160-7. doi: 10.1016/j.eururo.2014.09.019. Epub 2014 Oct 6. PMID:25301759

Broome AM, Ramamurthy G, Lavik K, Liggett A, Kinstlinger I, Basilion J. Optical Imaging of Targeted ¥_-Galactosidase in Brain Tumors to Detect EGFR Levels. Bioconjug Chem. 2015 Apr 15;26(4):660-8. doi: 10.1021/bc500597y. Epub 2015 Mar 30. PMID:25775241

Budd GT, Barlow WE, Moore HC, Hobday TJ, Stewart JA, Isaacs C, Salim M, Cho JK, Rinn KJ, Albain KS, Chew HK, Burton GV, Moore TD, Srkalovic G, McGregor BA, Flaherty LE, Livingston RB, Lew DL, Gralow JR, Hortobagyi GN. SWOG S0221: A Phase III Trial Comparing Chemotherapy Schedules in High-Risk Early-Stage Breast Cancer. J Clin Oncol. 2015. 1;33(1):58-64. PMCID:PMC4268253

Burger IA, Goldman DA, Vargas HA, Kattan MW, Yu C, Kou L, Andikyan V, Chi DS, Hricak H, Sala E. Incorporation of postoperative CT data into clinical models to predict 5-year overall and recurrence free survival after primary cytoreductive surgery for advanced ovarian cancer. Gynecol Oncol. 2015 Jun 17. doi:pii: S0090-8258(15)30032-9.  10.1016/j.ygyno.2015.06.010. [Epub ahead of print] PMID:26093061

Burke W, Appelbaum P, Dame L, Marshall P, Press N, Pyeritz R, Sharp R, Juengst E. The translational potential of research on the ethical, legal, and social implications of genomics. Genet Med. 2015. 17(1):12-20. PMCID:PMC4272334

Caimi PF, William BM, Silva CH, Fu P, Cooper BW, Campagnaro EL, Gerson SL, Reese-Koc J, Fox R, Creger RJ, De Lima M, Lazarus HM. Comparison of two BCNU - containing regimens in the Rituximab era. Excellent outcomes even in poor risk patients. Biol Blood Marrow Transplant. 2015 Jun 15. doi:pii: S1083-8791(15)00409-7.  10.1016/j.bbmt.2015.06.007. [Epub ahead of print] No abstract available. PMID:26087475

Caimi PF, William BM, Silva CH, Fu P, Cooper BW, Campagnaro EL, Gerson SL, Reese-Koc J, Fox R, Creger RJ, De Lima M, Lazarus HM. Comparison of two BCNU - containing regimens in the Rituximab era. Excellent outcomes even in poor risk patients. Biol Blood Marrow Transplant. 2015 Jun 15. doi:pii: S1083-8791(15)00409-7.  10.1016/j.bbmt.2015.06.007. [Epub ahead of print] No abstract available. PMID:26087475

Campbell LB, Kreicher KL, Gittleman HR, Strodtbeck K, Barnholtz-Sloan J, Bordeaux JS. Melanoma Incidence in Children and Adolescents: Decreasing Trends inë_the United States. J Pediatr. 2015 Jun;166(6):1505-13. doi: 10.1016/j.jpeds.2015.02.050. Epub 2015 Apr 9. PMID:25866386

Campbell LB, Kreicher KL, Gittleman HR, Strodtbeck K, Barnholtz-Sloan J, Bordeaux JS. Melanoma Incidence in Children and Adolescents: Decreasing Trends inξthe United States. J Pediatr. 2015 Jun;166(6):1505-13. doi: 10.1016/j.jpeds.2015.02.050. Epub 2015 Apr 9. PMID:25866386

Carew JS, Espitia CM, Zhao W, Mita MM, Mita AC, Nawrocki ST. Targeting survivin inhibits renal cell carcinoma progression and enhances the activity of temsirolimus. Mol Cancer Ther. 2015 Mar 25. doi:pii: molcanther.1036.2014. [Epub ahead of print] PMID:25808836

Cassano PA, Guertin KA, Kristal AR, Ritchie KA, Bertoia ML, Arnold KB, Crowley JJ, Hartline J, Goodman PJ, Tangen CM, Minasian LM, Lippman SM, Klein E. A randomized controlled trial of vitamin E and selenium on rate of decline in lung function. Respir Res. 2015 Mar 11;16(1):35. [Epub ahead of print] PMID:25889509 | PMCID:PMC4404242

Chakrabarti A, Banerjee S, Franchi L, Loo YM, Gale M Jr, Nê_ê±ez G, Silverman RH. RNase L Activates the NLRP3 Inflammasome during Viral Infections. Cell Host Microbe. 2015 Apr 8;17(4):466-77. doi: 10.1016/j.chom.2015.02.010. Epub 2015 Mar 26. PMID:25816776 | PMCID:PMC4393362

Chariou PL, Lee KL, Wen AM, Gulati NM, Stewart PL, Steinmetz NF. Detection and imaging of aggressive cancer cells using an epidermal growth factor receptor (EGFR)-targeted filamentous plant virus-based nanoparticle. Bioconjug Chem. 2015 Feb 18;26(2):262-9. doi: 10.1021/bc500545z. Epub 2015 Feb 5. PMID:25611133

Chase SM, Crabtree BF, Stewart EE, Nutting PA, Miller WL, Stange KC, Jaên CR. Coaching strategies for enhancing practice transformation. Fam Pract. 2015 Feb;32(1):75-81. doi: 10.1093/fampra/cmu062. Epub 2014 Oct 4. PMID:25281823

Chatterjee P, Choudhary GS, Alswillah T, Xiong X, Heston WD, Magi-Galluzzi C, Zhang J, Klein EA, Almasan A. The TMPRSS2-ERG Gene Fusion Blocks XRCC4-Mediated Nonhomologous End-Joining Repair and Radiosensitizes Prostate Cancer Cells to PARP Inhibition. Mol Cancer Ther. 2015 Aug;14(8):1896-906. doi: 10.1158/1535-7163.MCT-14-0865. Epub 2015 May 29. PMID:26026052 | PMCID:PMC4529796

Chatterjee P, Choudhary GS, Alswillah T, Xiong X, Heston WD, Magi-Galluzzi C, Zhang J, Klein EA, Almasan A. The TMPRSS2-ERG gene fusion blocks XRCC4-mediated non-homologous end-joining repair and radiosensitizes prostate cancer cells to PARP inhibition. Mol Cancer Ther. 2015 May 29. doi:pii: molcanther.0865.2014. [Epub ahead of print] PMID:26026052

Chen DJ, Falzarano SM, McKenney JK, Przybycin CG, Reynolds JP, Roma A, Jones JS, Stephenson A, Klein E, Magi-Galluzzi C. Does cumulative prostate cancer length (CCL) in prostate biopsies improve prediction of clinically insignificant cancer at radical prostatectomy in patients eligible for active surveillance? BJU Int. 2015 Aug;116(2):220-9. doi: 10.1111/bju.12880. Epub 2014 Dec 15. PMID:25060664

Chen J, Xu-Monette ZY, Deng L, Shen Q, Manyam GC, Martinez-Lopez A, Zhang L, Montes-Moreno S, Visco C, Tzankov A, Yin L, Dybkaer K, Chiu A, Orazi A, Zu Y, Bhagat G, Richards KL, Hsi ED, Choi WW, van Krieken JH, Huh J, Ponzoni M, et al. Dysregulated CXCR4 expression promotes lymphoma cell survival and independently predicts disease progression in germinal center B-cell-like diffuse large B-cell lymphoma. Oncotarget. 2015 Mar 20;6(8):5597-614. PMID:25704881

Chen X, Eads JR, Ammori JB, Kumar AM, Biswas T, Dorth JA. Adjuvant and neoadjuvant options in resectable gastric cancer: is there an optimal treatment approach? Curr Oncol Rep. 2015 Apr;17(4):18. doi: 10.1007/s11912-015-0442-4. PMID:25708803

Chen YB, Lane AA, Logan BR, Zhu X, Akpek G, Aljurf MD, Artz AS, Bredeson CN, Cooke KR, Ho VT, Lazarus HM, Olsson RF, Saber W, McCarthy PL, Pasquini MC. Impact of Conditioning Regimen on Outcomes for Patients with Lymphoma Undergoing High-Dose Therapy with Autologous Hematopoietic Cell Transplantation. Biol Blood Marrow Transplant. 2015 Feb 14. doi:pii: S1083-8791(15)00112-3.  10.1016/j.bbmt.2015.02.005. [Epub ahead of print] PMID:25687795

Chen YB, Lane AA, Logan BR, Zhu X, Akpek G, Aljurf MD, Artz AS, Bredeson CN, Cooke KR, Ho VT, Lazarus HM, Olsson RF, Saber W, McCarthy PL, Pasquini MC. Impact of conditioning regimen on outcomes for patients with lymphoma undergoing high-dose therapy with autologous hematopoietic cell transplantation. Biol Blood Marrow Transplant. 2015 Jun;21(6):1046-53. doi: 10.1016/j.bbmt.2015.02.005. Epub 2015 Feb 14. PMID:25687795 | PMCID:PMC4426014

Chen YB, Lane AA, Logan BR, Zhu X, Akpek G, Aljurf MD, Artz AS, Bredeson CN, Cooke KR, Ho VT, Lazarus HM, Olsson RF, Saber W, McCarthy PL, Pasquini MC. Impact of conditioning regimen on outcomes for patients with lymphoma undergoing high-dose therapy with autologous hematopoietic cell transplantation. Biol Blood Marrow Transplant. 2015 Jun;21(6):1046-53. doi: 10.1016/j.bbmt.2015.02.005. Epub 2015 Feb 14. PMID:25687795 | PMCID:PMC4426014

Cherian S, Kittel JA, Reddy CA, Kolar MD, Ulchaker J, Angermeier K, Stephans KL, Tendulkar RD, Klein E, Ciezki JP. Safety and efficacy of iodine-125 permanent prostate brachytherapy in patients with J-pouch anastomosis after total colectomy for ulcerative colitis. Pract Radiat Oncol. 2015 Apr 17. doi:pii: S1879-8500(15)00089-2.  10.1016/j.prro.2015.03.002. [Epub ahead of print] PMID:25899222

Chien LN, Ostrom QT, Gittleman H, Lin JW, Sloan AE, Barnett GH, Elder JB, McPherson C, Warnick R, Chiang YH, Lin CM, Rogers LR, Chiou HY, Barnholtz-Sloan JS. International Differences in Treatment and Clinical Outcomes for High Grade Glioma. PLoS One. 2015;10(6):e0129602. doi: 10.1371/journal.pone.0129602. PMID:26061037

Chien LN, Ostrom QT, Gittleman H, Lin JW, Sloan AE, Barnett GH, Elder JB, McPherson C, Warnick R, Chiang YH, Lin CM, Rogers LR, Chiou HY, Barnholtz-Sloan JS. International Differences in Treatment and Clinical Outcomes for High Grade Glioma. PLoS One. 2015;10(6):e0129602. doi: 10.1371/journal.pone.0129602. PMID:26061037

Choi E, Williamson SR, Montironi R, Zhang S, Wang M, Eble JN, Grignon DJ, Lopez-Beltran A, Idrees MT, Baldridge LA, Scarpelli M, Jones CL, Wang L, MacLennan GT, Osunkoya AO, Cheng L. Inflammatory myofibroblastic tumour of the urinary bladder: the role of immunoglobulin G4 and the comparison of two immunohistochemical antibodies and fluorescence in-situ hybridization for the detection of anaplastic lymphoma kinase alterations. Histopathology. 2015 Jul;67(1):20-38. doi: 10.1111/his.12619. Epub 2015 Jan 29. PMID:25406945

Choi H, Mazzone P. Preoperative evaluation of the patient with lung cancer being considered for lung resection. Curr Opin Anaesthesiol. 2015 Feb;28(1):18-25. doi: 10.1097/ACO.0000000000000149. PMID:25486485

Choi JS, Berdis AJ. Visualizing nucleic acid metabolism using non-natural nucleosides and nucleotide analogs. Biochim Biophys Acta. 2015 May 22. doi:pii: S1570-9639(15)00150-8.  10.1016/j.bbapap.2015.05.010. [Epub ahead of print] Review. PMID:26004088

Choi JS, Berdis AJ. Visualizing nucleic acid metabolism using non-natural nucleosides and nucleotide analogs. Biochim Biophys Acta. 2015 May 22. doi:pii: S1570-9639(15)00150-8.  10.1016/j.bbapap.2015.05.010. [Epub ahead of print] Review. PMID:26004088

Choi JS, Maity A, Gray T, Berdis AJ. A Metal-containing Nucleoside That Possesses Both Therapeutic and Diagnostic Activity against Cancer. J Biol Chem. 2015 Apr 10;290(15):9714-26. doi: 10.1074/jbc.M114.620294. Epub 2015 Feb 24. PMID:25713072 | PMCID:PMC4392271

Choksi NS, Fogel EL, Cote GA, Romagnuolo J, Elta GH, Scheiman JM, Chak A, Mosler P, Higgins PD, Korsnes SJ, Schmidt SE, Sherman S, Lehman GA, Elmunzer BJ; United States Cooperative for Outcomes Research in Endoscopy. The risk of post-ERCP pancreatitis and the protective effect of rectal indomethacin in cases of attempted but unsuccessful prophylactic pancreatic stent placement. Gastrointest Endosc. 2015. 81(1):150-5.

Choudhary GS, Tat TT, Misra S, Hill BT, Smith MR, Almasan A, Mazumder S. Cyclin E/Cdk2-dependent phosphorylation of Mcl-1 determines its stability and cellular sensitivity to BH3 mimetics. Oncotarget. 2015 Jul 10;6(19):16912-25. PMID:26219338

Christen WG, Glynn RJ, Gaziano JM, Darke AK, Crowley JJ, Goodman PJ, Lippman SM, Lad TE, Bearden JD, Goodman GE, Minasian LM, Thompson IM Jr, Blanke CD, Klein EA. Age-related cataract in men in the selenium and vitamin e cancer prevention trial eye endpoints study: a randomized clinical trial. JAMA Ophthalmol. 2015. 133(1):17-24.

Cooper BW, Kindwall-Keller TL, Craig MD, Creger RJ, Hamadani M, Tse WW, Lazarus HM. A Phase I Study of Midostaurin and Azacitidine in Relapsed and Elderly AML Patients. Clin Lymphoma Myeloma Leuk. 2015 Feb 16. doi:pii: S2152-2650(15)00046-4.  10.1016/j.clml.2015.02.017. [Epub ahead of print] PMID:25776192

Cooper DA, Banerjee S, Chakrabarti A, Garcê_a-Sastre A, Hesselberth JR, Silverman RH, Barton DJ. RNase L targets distinct sites in influenza A virus RNAs. J Virol. 2015 Mar;89(5):2764-76. doi: 10.1128/JVI.02953-14. Epub 2014 Dec 24. PMID:25540362 | PMCID:PMC4325751

Correa D, Somoza RA, Lin P, Schiemann WP, Caplan AI. Mesenchymal Stem Cells regulate Melanoma Cancer Cells extravasation to bone and liver at their perivascular niche. Int J Cancer. 2015 Aug 1. doi: 10.1002/ijc.29709. [Epub ahead of print] PMID:26235173

Cramer SA, Adjei IM, Labhasetwar V. Advancements in the delivery of epigenetic drugs. Expert Opin Drug Deliv. 2015 Mar 5:1-12. [Epub ahead of print] PMID:25739728

Daly BJ, Rosko A, Zhang S, Lazarus HM. The devil is in the details: confidentiality challenges in the age of genetics. HEC Forum. 2015 Mar;27(1):79-86. doi: 10.1007/s10730-014-9245-5. PMID:25085670

Das LM, Rosenjack J, Au L, Galle PS, Hansen MB, Cathcart MK, McCormick TS, Cooper KD, Silverstein RL, Lu KQ. Hyper-inflammation and skin destruction mediated by rosiglitazone activation of macrophages in IL-6 deficiency. J Invest Dermatol. 2015. 135(2):389-99.

de Blank PM, Ostrom QT, Rouse C, Wolinsky Y, Kruchko C, Salcido J, Barnholtz-Sloan JS. Years of life lived with disease and years of potential life lost in children who die of cancer in the United States, 2009. Cancer Med. 2015 Apr;4(4):608-19. doi: 10.1002/cam4.410. Epub 2015 Jan 27. PMID:25627000 | PMCID:PMC4402075

De S, Zhou H, DeSantis D, Croniger CM, Li X, Stark GR. Erlotinib protects against LPS-induced Endotoxicity because TLR4 needs EGFR to signal. Proc Natl Acad Sci U S A. 2015 Aug 4;112(31):9680-5. doi: 10.1073/pnas.1511794112. Epub 2015 Jul 20. PMID:26195767

Deb G, Thakur VS, Limaye AM, Gupta S. Epigenetic induction of tissue inhibitor of matrix metalloproteinase-3 by green tea polyphenols in breast cancer cells. Mol Carcinog. 2015 Jun;54(6):485-99. doi: 10.1002/mc.22121. Epub 2014 Jan 31. PMID:24481780

Della Porta MG, Tuechler H, Malcovati L, Schanz J, Sanz G, Garcia-Manero G, Solê F, Bennett JM, Bowen D, Fenaux P, Dreyfus F, Kantarjian H, Kuendgen A, Levis A, Cermak J, Fonatsch C, Le Beau MM, Slovak ML, Krieger O, Luebbert M, Maciejewski J, Magalhaes Validation of WHO classification-based Prognostic Scoring System (WPSS) for myelodysplastic syndromes and comparison with the revised International Prognostic Scoring System (IPSS-R). A study of the International Working Group for Prognosis in Myelodyspla Leukemia. 2015 Feb 27. doi: 10.1038/leu.2015.55. [Epub ahead of print] PMID:25721895

Demelash A, Pfannenstiel LW, Tannenbaum CS, Li X, Kalady MF, DeVecchio J, Gastman BR. Structure-Function Analysis of Mcl-1 Identifies a Novel Senescence Regulating Domain. J Biol Chem. 2015 Jul 23. doi:pii: jbc.M115.663898. [Epub ahead of print] PMID:26205817

DePry JL, Vyas R, Lazarus HM, Caimi PF, Gerstenblith MR, Bordeaux JS. Cutaneous Malignant Neoplasms in Hematopoietic Cell Transplant Recipients: A Systematic Review. JAMA Dermatol. 2015 Apr 22. doi: 10.1001/jamadermatol.2015.121. [Epub ahead of print] PMID:25902409

Doolittle E, Peiris PM, Doron G, Goldberg A, Tucci S, Rao S, Shah S, Sylvestre M, Govender P, Turan O, Lee Z, Schiemann WP, Karathanasis E. Spatiotemporal Targeting of a Dual-Ligand Nanoparticle to Cancer Metastasis. ACS Nano. 2015 Jul 28. [Epub ahead of print] PMID:26203676

Dowlati A CD 30 Molecular Celluarl Therapeutics. 2015. In Press

Duncan CN, Majhail NS, Brazauskas R, Wang Z, Cahn JY, Frangoul HA, Hayashi RJ, Hsu JW, Kamble RT, Kasow KA, Khera N, Lazarus HM, Loren AW, Marks DI, Maziarz RT, Mehta P, Myers KC, Norkin M, Pidala JA, Porter DL, Reddy V, Saber W, et al. Long-Term Survival and Late Effects among One-Year Survivors of Second Allogeneic Hematopoietic Cell Transplantation for Relapsed Acute Leukemia and Myelodysplastic Syndromes. Biol Blood Marrow Transplant. 2015. 21(1):151-8. PMCID:PMC4272862

Ellingson BM, Bendszus M, Boxerman J, Barboriak D, Erickson BJ, Smits M, Nelson SJ, Gerstner E, Alexander B, Goldmacher G, Wick W, Vogelbaum M, Weller M, Galanis E, Kalpathy-Cramer J, Shankar L, Jacobs P, Pope WB, Yang D, Chung C, Knopp MV, Cha S, et al. Consensus recommendations for a standardized Brain Tumor Imaging Protocol in clinical trials. Neuro Oncol. 2015 Aug 5. doi:pii: nov095. [Epub ahead of print] Review. PMID:26250565

Epstein JI, Zelefsky MJ, Sjoberg DD, Nelson JB, Egevad L, Magi-Galluzzi C, Vickers AJ, Parwani AV, Reuter VE, Fine SW, Eastham JA, Wiklund P, Han M, Reddy CA, Ciezki JP, Nyberg T, Klein EA. A Contemporary Prostate Cancer Grading System: A Validated Alternative to the Gleason Score. Eur Urol. 2015 Jul 9. doi:pii: S0302-2838(15)00557-6.  10.1016/j.eururo.2015.06.046. [Epub ahead of print] PMID:26166626

Escudier B, Rini BI, Motzer RJ, Tarazi J, Kim S, Huang X, Rosbrook B, English PA, Loomis AK, Williams JA. Genotype Correlations With Blood Pressure and Efficacy From a Randomized Phase III Trial of Second-Line Axitinib Versus Sorafenib in Metastatic Renal Cell Carcinoma. Clin Genitourin Cancer. 2015 Aug;13(4):328-337.e3. doi: 10.1016/j.clgc.2015.02.007. Epub 2015 Feb 21. PMID:25816720

Estephan F, Rogers HJ, Visconte V, Tabarroki A, Ai J, Duong HK, Kalaycio M, Tiu RV. Spontaneous recovery of severe nilotinib-induced bone marrow aplasia and successful retreatment with dasatinib in a patient with Chronic Phase Chronic Myeloid Leukemia. Leuk Lymphoma. 2015 Mar;56(3):811-3. doi: 10.3109/10428194.2014.935367. Epub 2014 Jul 17. No abstract available. PMID:24956141

Eswarappa SM, Fox PL. Antiangiogenic VEGF-Ax: A New Participant in Tumor Angiogenesis. Cancer Res. 2015 Jul 15;75(14):2765-9. doi: 10.1158/0008-5472.CAN-14-3805. Epub 2015 Jun 29. Review. PMID:26122849 | PMCID:PMC4506224

Evens AM, Kanakry JA, Sehn LH, Kritharis A, Feldman T, Kroll A, Gascoyne RD, Abramson JS, Petrich AM, Hernandez-Ilizaliturri FJ, Al-Mansour Z, Adeimy C, Hemminger J, Bartlett NL, Mato A, Caimi PF, Advani RH, Klein AK, Nabhan C, Smith SM, Fabregas JC, Loss Gray zone lymphoma with features intermediate between classical hodgkin lymphoma and diffuse large B-cell lymphoma: Characteristics, outcomes, and prognostication among a large multicenter cohort. Am J Hematol. 2015 Jun 4. doi: 10.1002/ajh.24082. [Epub ahead of print] PMID:26044261

Falzarano SM, Ferro M, Bollito E, Klein EA, Carrieri G, Magi-Galluzzi C. Novel biomarkers and genomic tests in prostate cancer: a critical analysis. Minerva Urol Nefrol. 2015 Jun 9. [Epub ahead of print] PMID:26054411

Fink SP, Dawson DM, Zhang Y, Kresak A, Lawrence EG, Yang P, Chen Y, Barnholtz-Sloan JS, Willis JE, Kopelovich L, Markowitz SD. Sulindac reversal of 15-PGDH-mediated resistance to colon tumor chemoprevention with NSAIDs. Carcinogenesis. 2015 Feb;36(2):291-8. doi: 10.1093/carcin/bgu241. Epub 2014 Dec 10. PMID:25503930 | PMCID:PMC4322189

Fizazi K, Jones R, Oudard S, Efstathiou E, Saad F, de Wit R, De Bono J, Cruz FM, Fountzilas G, Ulys A, Carcano F, Agarwal N, Agus D, Bellmunt J, Petrylak DP, Lee SY, Webb IJ, Tejura B, Borgstein N, Dreicer R. Phase III, randomized, double-blind, multicenter trial comparing orteronel (TAK-700) plus prednisone with placebo plus prednisone in patients with metastatic castration-resistant prostate cancer that has progressed during or after docetaxel-based therapy: J Clin Oncol. 2015 Mar 1;33(7):723-31. doi: 10.1200/JCO.2014.56.5119. Epub 2015 Jan 26. PMID:25624429

Fu S, Rybicki L, Abounader D, Andresen S, Bolwell BJ, Dean R, Gerds A, Hamilton BK, Hanna R, Hill BT, Jagadeesh D, Kalaycio ME, Liu HD, Pohlman B, Sobecks RM, Majhail NS. Association of socioeconomic status with long-term outcomes in 1-year survivors of allogeneic hematopoietic cell transplantation. Bone Marrow Transplant. 2015 Jul 20. doi: 10.1038/bmt.2015.166. [Epub ahead of print] PMID:26191953

Fu X, Patel D, Zhu H, MacLennan G, Wang YT, Jenkins MW, Rollins AM. Miniature forward-viewing common-path OCT probe for imaging the renal pelvis. Biomed Opt Express. 2015 Apr 1;6(4):1164-71. doi: 10.1364/BOE.6.001164. PMID:25909002

Gajra A, Klepin HD, Feng T, Tew WP, Mohile SG, Owusu C, Gross CP, Lichtman SM, Wildes TM, Chapman AE, Dotan E, Katheria V, Zavala L, Akiba C, Hurria A; Cancer and Aging Research Group (CARG). Predictors of chemotherapy dose reduction at first cycle in patients age 65years and older with solid tumors. J Geriatr Oncol. 2015 Mar;6(2):133-40. doi: 10.1016/j.jgo.2014.12.002. Epub 2015 Feb 7. PMID:25666905

Gerds AT, Sekeres MA. Albumin as a prognostic marker in myelodysplastic syndromes: still relevant after all these years. Leuk Lymphoma. 2015 May 25:1-2. [Epub ahead of print] No abstract available. PMID:25904379

Gerstner ER, Ye X, Duda DG, Levine MA, Mikkelsen T, Kaley TJ, Olson JJ, Nabors BL, Ahluwalia MS, Wen PY, Jain RK, Batchelor TT, Grossman S. A phase I study of cediranib in combination with cilengitide in patients with recurrent glioblastoma. Neuro Oncol. 2015 May 24. doi:pii: nov085. [Epub ahead of print] PMID:26008604

Ginsburg SB, Viswanath SE, Bloch BN, Rofsky NM, Genega EM, Lenkinski RE, Madabhushi A. Novel PCA-VIP scheme for ranking MRI protocols and identifying computer-extracted MRI measurements associated with central gland and peripheral zone prostate tumors. J Magn Reson Imaging. 2015 May;41(5):1383-93. doi: 10.1002/jmri.24676. Epub 2014 Jun 18. PMID:24943647

Gittleman HR, Ostrom QT, Rouse CD, Dowling JA, de Blank PM, Kruchko CA, Elder JB, Rosenfeld SS, Selman WR, Sloan AE, Barnholtz-Sloan JS. Trends in central nervous system tumor incidence relative to other common cancers in adults, adolescents, and children in the United States, 2000 to 2010. Cancer. 2015. 121(1):102-12.

Goebel TE, Schiltz NK, Woodside KJ, Pillai AC, Caimi PF, Lazarus HM, Koroukian SM, Campagnaro EL. Neoplastic and Non-Neoplastic Complications of Solid Organ Transplantation in Patients with Preexisting Monoclonal Gammopathy of Undetermined Significance (MGUS). Clin Transplant. 2015 Jul 21. doi: 10.1111/ctr.12595. [Epub ahead of print] PMID:26194021

Gong Y, Ma Y, Sinyuk M, Loganathan S, Thompson RC, Sarkaria JN, Chen W, Lathia JD, Mobley BC, Clark SW, Wang J. Insulin-mediated signaling promotes proliferation and survival of glioblastoma through Akt activation. Neuro Oncol. 2015 Jul 1. doi:pii: nov096. [Epub ahead of print] PMID:26136493

Gowrishankar B, Przybycin CG, Ma C, Nandula SV, Rini B, Campbell S, Klein E, Chaganti RS, Magi-Galluzzi C, Houldsworth J. A genomic algorithm for the molecular classification of common renal cortical neoplasms: development and validation. J Urol. 2015 May;193(5):1479-85. doi: 10.1016/j.juro.2014.11.099. Epub 2014 Dec 11. PMID:25498568

Goyal SD, Zhang MJ, Wang HL, Akpek G, Copelan EA, Freytes C, Gale RP, Hamadani M, Inamoto Y, Kamble RT, Lazarus HM, Marks DI, Nishihori T, Olsson RF, Reshef R, Ritchie DS, Saber W, Savani BN, Seber A, Shea TC, Tallman MS, Wirk B, et al. Allogeneic hematopoietic cell transplant for AML: no impact of pre-transplant extramedullary disease on outcome. Bone Marrow Transplant. 2015 Aug;50(8):1057-62. doi: 10.1038/bmt.2015.82. Epub 2015 Apr 27. PMID:25915806 | PMCID:PMC4527880

Guda K, Veigl ML, Varadan V, Nosrati A, Ravi L, Lutterbaugh J, Beard L, Willson JK, Sedwick WD, Wang ZJ, Molyneaux N, Miron A, Adams MD, Elston RC, Markowitz SD, Willis JE. Reply to Ashktorab et al.: Mutational landscape of colon cancers in African Americans. Proc Natl Acad Sci U S A. 2015 Jun 2;112(22):E2853. doi: 10.1073/pnas.1505059112. Epub 2015 May 4. No abstract available. PMID:25941411 | PMCID:PMC4460466

Gudino N, Sonmez M, Yao Z, Baig T, Nielles-Vallespin S, Faranesh AZ, Lederman RJ, Martens M, Balaban RS, Hansen MS, Griswold MA. Parallel transmit excitation at 1.5 T based on the minimization of a driving function for device heating. Med Phys. 2015. 42(1):359. PMCID:PMC4282679

Ha D, Choi H, Zell K, Raymond DP, Stephans K, Wang XF, Videtic G, McCarthy K, Minai OA, Mazzone PJ. Association of impaired heart rate recovery with cardiopulmonary complications after lung cancer resection surgery. J Thorac Cardiovasc Surg. 2015 Apr;149(4):1168-1173.e3. doi: 10.1016/j.jtcvs.2014.11.037. Epub 2014 Nov 21. PMID:25583106

Halabi S, Rini BI, Escudier B, Stadler WM, Small EJ. Progression-free survival: Does a correlation with survival justify its role as a surrogate clinical endpoint? Cancer. 2015 Jun 1;121(11):1906. doi: 10.1002/cncr.29252. Epub 2015 Feb 11. No abstract available. PMID:25677867

Hamilton BK, Law AD, Rybicki L, Abounader D, Dabney J, Dean R, Duong HK, Gerds AT, Hanna R, Hill BT, Jagadeesh D, Kalaycio ME, Lawrence C, McLellan L, Pohlman B, Sobecks RM, Bolwell BJ, Majhail NS. Prognostic significance of pre-transplant quality of life in allogeneic hematopoietic cell transplantation recipients. Bone Marrow Transplant. 2015 Jun 1. doi: 10.1038/bmt.2015.122. [Epub ahead of print] PMID:26030045

Hamilton BK, Rybicki L, Abounader D, Andresen S, Kalaycio M, Sobecks R, Pohlman B, Hanna R, Dean R, Liu H, Hill B, Bolwell B, Copelan E. Long-term survival after high-dose chemotherapy with autologous hematopoietic cell transplantation in metastatic breast cancer. Hematol Oncol Stem Cell Ther. 2015 Jul 7. doi:pii: S1658-3876(15)00057-6.  10.1016/j.hemonc.2015.06.005. [Epub ahead of print] PMID:26183670

Hamilton BK, Rybicki L, Dean R, Majhail NS, Haddad H, Abounader D, Hanna R, Sobecks R, Duong H, Hill BT, Copelan E, Bolwell B, Kalaycio M. Cyclosporine in combination with mycophenolate mofetil versus methotrexate for graft versus host disease prevention in myeloablative HLA-identical sibling donor allogeneic hematopoietic cell transplantation. Am J Hematol. 2015 Feb;90(2):144-8. doi: 10.1002/ajh.23882. Epub 2014 Nov 19. PMID:25353395

Hamilton BK, Rybicki L, Sekeres M, Kalaycio M, Hanna R, Sobecks R, Dean R, Duong H, Hill BT, Bolwell B, Copelan E. Racial differences in allogeneic hematopoietic cell transplantation outcomes among African Americans and whites. Bone Marrow Transplant. 2015 Jun;50(6):834-9. doi: 10.1038/bmt.2015.44. Epub 2015 Mar 23. PMID:25798671

Han X, Mayca Pozo F, Wisotsky JN, Wang B, Jacobberger JW, Zhang Y. Phosphorylation of Minichromosome Maintenance 3 (MCM3) by Checkpoint Kinase 1 (Chk1) Negatively Regulates DNA Replication and Checkpoint Activation. J Biol Chem. 2015 May 8;290(19):12370-8. doi: 10.1074/jbc.M114.621532. Epub 2015 Mar 25. PMID:25809478 | PMCID:PMC4424366

Han Y, Hazelett DJ, Wiklund F, Schumacher FR, Stram DO, Berndt SI, Wang Z, Rand KA, Hoover RN, Machiela MJ, Yeager M, Burdette L, Chung CC, Hutchinson A, Yu K, Xu J, Travis RC, Key TJ, Siddiq A, Canzian F, Takahashi A, Kubo M, et al. Integration of multiethnic fine-mapping and genomic annotation to prioritize candidate functional SNPs at prostate cancer susceptibility regions. Hum Mol Genet. 2015 Jul 10. doi:pii: ddv269. [Epub ahead of print] PMID:26162851

Han Z, Zhou Z, Shi X, Wang J, Wu X, Sun D, Chen Y, Zhu H, Magi-Galluzzi C, Lu ZR. EDB Fibronectin Specific Peptide for Prostate Cancer Targeting. Bioconjug Chem. 2015 Apr 15. [Epub ahead of print] PMID:25848940

Hasan S, Francis A, Hagenauer A, Hirsh A, Kaminsky D, Traughber B, Abouassaly R, Ellis R. The role of brachytherapy in organ preservation for penile cancer: A meta-analysis and review of the literature. Brachytherapy. 2015 Jul-Aug;14(4):517-524. doi: 10.1016/j.brachy.2015.03.008. Epub 2015 May 2. Review. PMID:25944394

Hayashi Y, Bardsley MR, Toyomasu Y, Milosavljevic S, Gajdos GB, Choi KM, Reid-Lombardo K, Kendrick ML, Bingener-Casey J, Tang CM, Sicklick JK, Gibbons SJ, Farrugia G, Taguchi T, Gupta A, Rubin BP, Fletcher JA, Ramachandran A, Ordog T. PDGFRA Regulates Proliferation of Gastrointestinal Stromal Tumor Cells with Mutations in KIT by Stabilizing ETV1. Gastroenterology. 2015 Apr 9. doi:pii: S0016-5085(15)00497-7.  10.1053/j.gastro.2015.04.006. [Epub ahead of print] PMID:25865047

Hayashi Y, Bardsley MR, Toyomasu Y, Milosavljevic S, Gajdos GB, Choi KM, Reid-Lombardo K, Kendrick ML, Bingener-Casey J, Tang CM, Sicklick JK, Gibbons SJ, Farrugia G, Taguchi T, Gupta A, Rubin BP, Fletcher JA, Ramachandran A, Ordog T. Platelet-Derived Growth Factor Receptor-ë± Regulates Proliferation of Gastrointestinal Stromal Tumor Cells With Mutations in KIT by Stabilizing ETV1. Gastroenterology. 2015 Aug;149(2):420-432.e16. doi: 10.1053/j.gastro.2015.04.006. Epub 2015 Apr 9. PMID:25865047 | PMCID:PMC4516576

Hdeib A, Sloan AE. Dendritic cell immunotherapy for solid tumors: evaluation of the DCVax(ÔÎ) platform in the treatment of glioblastoma multiforme. CNS Oncol. 2015 Mar;4(2):63-9. doi: 10.2217/cns.14.54. PMID:25768330

Heist RS, Duda DG, Sahani DV, Ancukiewicz M, Fidias P, Sequist LV, Temel JS, Shaw AT, Pennell NA, Neal JW, Gandhi L, Lynch TJ, Engelman JA, Jain RK. Improved tumor vascularization after anti-VEGF therapy with carboplatin and nab-paclitaxel associates with survival in lung cancer. Proc Natl Acad Sci U S A. 2015 Feb 3;112(5):1547-52. doi: 10.1073/pnas.1424024112. Epub 2015 Jan 20. PMID:25605928 | PMCID:PMC4321320

Hileman CO, Kinley B, Scharen-Guivel V, Melbourne K, Szwarcberg J, Robinson J, Lederman MM, McComsey GA. Differential Reduction in Monocyte Activation and Vascular Inflammation with Integrase Inhibitor-Based Initial Antiretroviral Therapy. J Infect Dis. 2015. In Press

Holter-Chakrabarty JL, Pierson N, Zhang MJ, Zhu X, Akpek G, Aljurf MD, Artz AS, Baron F, Bredeson CN, Dvorak CC, Epstein RB, Lazarus HM, Olsson RF, Selby GB, Williams KM, Cooke KR, Pasquini MC, McCarthy PL. The Sequence of Cyclophosphamide and Myeloablative Total Body Irradiation in Hematopoietic Cell Transplantation for Patients with Acute Leukemia. Biol Blood Marrow Transplant. 2015 Mar 31. doi:pii: S1083-8791(15)00217-7.  10.1016/j.bbmt.2015.03.017. [Epub ahead of print] PMID:25840335

Hong CW, Reddy CA, Wilkinson DA, Klein EA, Ciezki JP. Influence of zonal dosimetry on prostate brachytherapy outcomes. J Contemp Brachytherapy. 2015 Feb;7(1):17-22. doi: 10.5114/jcb.2015.48875. Epub 2015 Feb 4. PMID:25829932 | PMCID:PMC4371063

Hou D, Koyuturk M. Comprehensive evaluation of composite gene features in cancer outcome prediction. Cancer Inform. 2014;13(Suppl 3):93-104. doi: 10.4137/CIN.S14028. PMID:25780335 | PMCID:PMC4345828

Hsieh J, Elson P, Otvos B, Rose J, Loftus C, Rahmathulla G, Angelov L, Barnett G, Weil R, Vogelbaum MA. Tumor Progression in Patients Receiving Adjuvant Whole-Brain Radiotherapy vs Localized Radiotherapy After Surgical Resection of Brain Metastases. Neurosurgery. 2015. In Press

Hsu JW, Wingard JR, Logan BR, Chitphakdithai P, Akpek G, Anderlini P, Artz AS, Bredeson C, Goldstein S, Hale G, Hematti P, Joshi S, Kamble RT, Lazarus HM, O'Donnell PV, Pulsipher MA, Savani BN, Schears RM, Shaw BE, Confer DL. Race and ethnicity influences collection of granulocyte colony-stimulating factor-mobilized peripheral blood progenitor cells from unrelated donors, a center for international blood and marrow transplant research analysis. Biol Blood Marrow Transplant. 2015. 21(1):165-71. PMCID:PMC4272878

Hu K, Ting AH, Li J. BSPAT: a fast online tool for DNA methylation co-occurrence pattern analysis based on high-throughput bisulfite sequencing data. BMC Bioinformatics. 2015 Jul 11;16:220. doi: 10.1186/s12859-015-0649-2. PMID:26163275 | PMCID:PMC4499179

Huang D, Nagata Y, Grossmann V, Radivoyevitch T, Okuno Y, Nagae G, Hosono N, Schnittger S, Sanada M, Przychodzen B, Kon A, Polprasert C, Shen W, Clemente MJ, Phillips JG, Alpermann T, Yoshida K, Nadarajah N, Sekeres MA, Oakley K, Nguyen N, Shiraishi Y, et BRCC3 mutations in myeloid neoplasms. Haematologica. 2015 May 22. doi:pii: haematol.2014.111989. [Epub ahead of print] PMID:26001790

Humm JL, Sartor O, Parker C, Bruland OS, Macklis R. Radium-223 in the Treatment of Osteoblastic Metastases: A Critical Clinical Review. Int J Radiat Oncol Biol Phys. 2015 Apr 1;91(5):898-906. doi: 10.1016/j.ijrobp.2014.12.061. Review. PMID:25832684

Ignatz-Hoover JJ, Wang H, Moreton SA, Chakrabarti A, Agarwal MK, Sun K, Gupta K, Wald DN. The role of TLR8 signaling in acute myeloid leukemia differentiation. Leukemia. 2015 Apr;29(4):918-26. doi: 10.1038/leu.2014.293. Epub 2014 Oct 6. PMID:25283842 | PMCID:PMC4387126

Inamoto Y, Shah NN, Savani BN, Shaw BE, Abraham AA, Ahmed IA, Akpek G, Atsuta Y, Baker KS, Basak GW, Bitan M, DeFilipp Z, Gregory TK, Greinix HT, Hamadani M, Hamilton BK, Hayashi RJ, Jacobsohn DA, Kamble RT, Kasow KA, Khera N, Lazarus HM, et al. Secondary solid cancer screening following hematopoietic cell transplantation. Bone Marrow Transplant. 2015 Mar 30. doi: 10.1038/bmt.2015.63. [Epub ahead of print] Review. PMID:25822223

Jain S, Loblaw A, Vesprini D, Zhang L, Kattan MW, Mamedov A, Jethava V, Sethukavalan P, Yu C, Klotz L. Gleason Upgrading with Time in a Large Prostate Cancer Active Surveillance Cohort. J Urol. 2015 Feb 4. doi:pii: S0022-5347(15)00213-X.  10.1016/j.juro.2015.01.102. [Epub ahead of print] PMID:25660208

Jalali A, Amirian ES, Bainbridge MN, Armstrong GN, Liu Y, Tsavachidis S, Jhangiani SN, Plon SE, Lau CC, Claus EB, Barnholtz-Sloan JS, Il'yasova D, Schildkraut J, Ali-Osman F, Sadetzki S, Johansen C, Houlston RS, Jenkins RB, Lachance D, Olson SH, Bernstein Targeted sequencing in chromosome 17q linkage region identifies familial glioma candidates in the Gliogene Consortium. Sci Rep. 2015 Feb 5;5:8278. doi: 10.1038/srep08278. PMID:25652157 | PMCID:PMC4317686

Javidi-Sharifi N, Traer E, Martinez J, Gupta A, Taguchi T, Dunlap J, Heinrich MC, Corless CL, Rubin BP, Druker BJ, Tyner JW. Crosstalk between KIT and FGFR3 Promotes Gastrointestinal Stromal Tumor Cell Growth and Drug Resistance. Cancer Res. 2015 Mar 1;75(5):880-91. doi: 10.1158/0008-5472.CAN-14-0573. Epub 2014 Nov 28. PMID:25432174 | PMCID:PMC4348216

Jernigan AM, Mahdi H, Rose PG. Epithelial Ovarian Cancer Metastatic to the Central Nervous System and a Family History Concerning for Hereditary Breast and Ovarian Cancer-A Potential Relationship. Int J Gynecol Cancer. 2015 Jun 9. [Epub ahead of print] PMID:26067864

Jernigan AM, Maurer KA, Cooper K, Schauer PR, Rose PG, Michener CM. Referring survivors of endometrial cancer and complex atypical hyperplasia to bariatric specialists: a prospective cohort study. Am J Obstet Gynecol. 2015 May 14. doi:pii: S0002-9378(15)00478-0.  10.1016/j.ajog.2015.05.015. [Epub ahead of print] PMID:25981846

Johnson LM, Leek AC, Drotar D, Noll RB, Rheingold SR, Kodish ED, Baker JN. Practical communication guidance to improve phase 1 informed consent conversations and decision-making in pediatric oncology. Cancer. 2015 Jul 15;121(14):2439-48. doi: 10.1002/cncr.29354. Epub 2015 Apr 14. PMID:25873253 | PMCID:PMC4490010

Kalra S, Rini BI, Jonasch E. Alternate sunitinib schedules in patients with metastatic renal cell carcinoma. Ann Oncol. 2015 Jul;26(7):1300-4. doi: 10.1093/annonc/mdv030. Epub 2015 Jan 26. Review. PMID:25628443 | PMCID:PMC4490228

Kanakry CG, de Lima MJ, Luznik L. Alternative Donor Allogeneic Hematopoietic Cell Transplantation for Acute Myeloid Leukemia. Semin Hematol. 2015 Jul;52(3):232-42. doi: 10.1053/j.seminhematol.2015.03.005. Epub 2015 Mar 18. Review. PMID:26111471 | PMCID:PMC4483196

Kang KH, Okoye CC, Patel RB, Siva S, Biswas T, Ellis RJ, Yao M, Machtay M, Lo SS. Complications from Stereotactic Body Radiotherapy for Lung Cancer. Cancers (Basel). 2015 Jun 15;7(2):981-1004. doi: 10.3390/cancers7020820. Review. PMID:26083933

Karmali R, Dalovisio A, Borgia JA, Venugopal P, Kim BW, Szymanski KG, Hari P, Lazarus H. All in the family: Clueing into the link between metabolic syndrome and hematologic malignancies. Blood Rev. 2015 Mar;29(2):71-80. doi: 10.1016/j.blre.2014.09.010. Epub 2014 Sep 28. PMID:25433571

Kattan MW, Gerds TA. Comparison of two ordinal prediction models: A cancer staging system example. Clin Trials. 2015 Aug;12(4):342-7. doi: 10.1177/1740774515572614. Epub 2015 Feb 19. PMID:25701155

Keng MK, Thallner EA, Elson P, Ajon C, Sekeres J, Wenzell CM, Seastone DJ, Gallagher EM, Weber CM, Earl MA, Mukherjee S, Pohlman B, Cober E, Foster VB, Yuhas J, Kalaycio ME, Bolwell BJ, Sekeres MA. Reducing Time to Antibiotic Administration for Febrile Neutropenia in the Emergency Department. J Oncol Pract. 2015 Jul 28. doi:pii: JOP.2014.002733. [Epub ahead of print] PMID:26220930

Kenison TC, Silverman P, Sustin M, Thompson CL. Differences between nurse practitioner and physician care providers on rates of secondary cancer screening and discussion of lifestyle changes among breast cancer survivors. J Cancer Surviv. 2015 Jun;9(2):223-9. doi: 10.1007/s11764-014-0405-z. Epub 2014 Oct 9. PMID:25297542

Khorana AA. Cancer Workup after Unprovoked Clot - Less Is More. N Engl J Med. 2015 Jun 22. [Epub ahead of print] No abstract available. PMID:26098558

Kiechle J, Pahwa S, Gulani V, Kanaan G, Sedelaar J, Ponsky L. Magnetic resonance imaging for prostate cancer: what the urologist needs to know. Minerva Urol Nefrol. 2015 Sep;67(3):201-10. Epub 2015 Jun 9. PMID:26054410

Kim ES, Bernstein D, Hilsenbeck SG, Chung CH, Dicker AP, Ersek JL, Stein S, Khuri FR, Burgess E, Hunt K, Ivy P, Bruinooge SS, Meropol N, Schilsky RL. Modernizing Eligibility Criteria for Molecularly Driven Trials. J Clin Oncol. 2015 Jul 20. doi:pii: JCO.2015.62.1854. [Epub ahead of print] PMID:26195710

Kim H, Zheng S, Amini SS, Virk SM, Mikkelsen T, Brat DJ, Grimsby J, Sougnez C, Muller F, Hu J, Sloan AE, Cohen ML, Van Meir EG, Scarpace L, Laird PW, Weinstein JN, Lander ES, Gabriel S, Getz G, Meyerson M, Chin L, Barnholtz-Sloan JS, et al. Whole-genome and multisector exome sequencing of primary and post-treatment glioblastoma reveals patterns of tumor evolution. Genome Res. 2015 Mar;25(3):316-27. doi: 10.1101/gr.180612.114. Epub 2015 Feb 3. PMID:25650244 | PMCID:PMC4352879

Kim SH, Joshi K, Ezhilarasan R, Myers TR, Siu J, Gu C, Nakano-Okuno M, Taylor D, Minata M, Sulman EP, Lee J, Bhat KP, Salcini AE, Nakano I. EZH2 protects glioma stem cells from radiation-induced cell death in a MELK/FOXM1-dependent manner. Stem Cell Reports. 2015 Feb 10;4(2):226-38. doi: 10.1016/j.stemcr.2014.12.006. Epub 2015 Jan 15. PMID:25601206 | PMCID:PMC4325196

Kim SH, Kim EJ, Hitomi M, Oh SY, Jin X, Jeon HM, Beck S, Jin X, Kim JK, Park CG, Chang SY, Yin J, Kim T, Jeon YJ, Song J, Lim YC, Lathia JD, Nakano I, Kim H. The LIM-only transcription factor LMO2 determines tumorigenic and angiogenic traits in glioma stem cells. Cell Death Differ. 2015 Feb 27. doi: 10.1038/cdd.2015.7. [Epub ahead of print] PMID:25721045

Kim YW, Yakubenko VP, West XZ, Gugiu GB, Kutralanathan R, Biswas S, Gao D, Crabb JW, Salomon RG, Podrez E, Byzova T. Receptor-Mediated Mechanism Controlling Tissue Levels of Bioactive Lipid Oxidation Products. Circ Res. 2015 May 12. doi:pii: CIRCRESAHA.114.305925. [Epub ahead of print] PMID:25966710

Kinney SN, Eble JN, Hes O, Williamson SR, Grignon DJ, Wang M, Zhang S, Baldrige LA, Martignoni G, Brunelli M, Wang L, Comperat E, Fan R, Montironi R, MacLennan GT, Cheng L. Metanephric adenoma: the utility of immunohistochemical and cytogenetic analyses in differential diagnosis, including solid variant papillary renal cell carcinoma and epithelial-predominant nephroblastoma. Mod Pathol. 2015 Aug 7. doi: 10.1038/modpathol.2015.81. [Epub ahead of print] PMID:26248896

Kittel JA, Reddy CA, Smith KL, Stephans KL, Tendulkar RD, Ulchaker J, Angermeier K, Campbell S, Stephenson A, Klein EA, Wilkinson DA, Ciezki JP. Long-Term Efficacy and Toxicity of Low-Dose-Rate (125)I Prostate Brachytherapy as Monotherapy in Low-, Intermediate-, and High-Risk Prostate Cancer. Int J Radiat Oncol Biol Phys. 2015 Jul 15;92(4):884-93. doi: 10.1016/j.ijrobp.2015.02.047. Epub 2015 May 8. PMID:25962627

Klein EA, Yousefi K, Haddad Z, Choeurng V, Buerki C, Stephenson AJ, Li J, Kattan MW, Magi-Galluzzi C, Davicioni E. A Genomic Classifier Improves Prediction of Metastatic Disease Within 5 Years After Surgery in Node-negative High-risk Prostate Cancer Patients Managed by Radical Prostatectomy Without Adjuvant Therapy. Eur Urol. 2015 Apr;67(4):778-86. doi: 10.1016/j.eururo.2014.10.036. Epub 2014 Nov 12. PMID:25466945

Klein EA. Prostate cancer: MR-TRUS fusion biopsy-defining a new standard. Nat Rev Clin Oncol. 2015 Apr 14. doi: 10.1038/nrclinonc.2015.70. [Epub ahead of print] No abstract available. PMID:25869459

Klein EA. Seeing and not believing: oligometastases and the future of metastatic prostate cancer. Eur Urol. 2015 May;67(5):864-5. doi: 10.1016/j.eururo.2014.09.035. Epub 2014 Oct 11. No abstract available. PMID:25311954

Ko JJ, Xie W, Kroeger N, Lee JL, Rini BI, Knox JJ, Bjarnason GA, Srinivas S, Pal SK, Yuasa T, Smoragiewicz M, Donskov F, Kanesvaran R, Wood L, Ernst DS, Agarwal N, Vaishampayan UN, Rha SY, Choueiri TK, Heng DY. The International Metastatic Renal Cell Carcinoma Database Consortium model as a prognostic tool in patients with metastatic renal cell carcinoma previously treated with first-line targeted therapy: a population-based study. Lancet Oncol. 2015 Mar;16(3):293-300. doi: 10.1016/S1470-2045(14)71222-7. Epub 2015 Feb 12. PMID:25681967

Koroukian SM, Bakaki PM, Han X, Schluchter M, Owusu C, Cooper GS, Flocke SA. Lasting Effects of the Breast and Cervical Cancer Early Detection Program on Breast Cancer Detection and Outcomes, Ohio, 2000-2009. Prev Chronic Dis. 2015 Jul 23;12:E116. doi: 10.5888/pcd12.140491. PMID:26203814 | PMCID:PMC4515916

Koroukian SM, Warner DF, Owusu C, Given CW. Multimorbidity redefined: prospective health outcomes and the cumulative effect of co-occurring conditions. Prev Chronic Dis. 2015 Apr 23;12:E55. doi: 10.5888/pcd12.140478. PMID:25906436

Koroukian SM. Analyzing Cancer Disparities: A New Policy Landscape Calls for New Approaches to Research. J Public Health Manag Pract. 2015 Sep-Oct;21(5):417-8. doi: 10.1097/PHH.0000000000000292. No abstract available. PMID:26214534 | PMCID:PMC4518456

Koroukian SM. Capsule Commentary on Chawla et al., Unveiling SEER-CAHPSÔÎ: A New Data Resource for Quality of Care Research. J Gen Intern Med. 2015 May;30(5):655. doi: 10.1007/s11606-015-3198-5. No abstract available. PMID:25637553 | PMCID:PMC4395598

Koroukian SM. Dual-eligibility status: a marker of vulnerability and cancer-related disparities. J Clin Oncol. 2015 Feb 1;33(4):297-8. doi: 10.1200/JCO.2014.59.1933. Epub 2014 Dec 22. No abstract available. PMID:25534379

Kotecha R, Zimmerman A, Murphy ES, Ahmed Z, Ahluwalia MS, Suh JH, Reddy CA, Angelov L, Vogelbaum MA, Barnett GH, Chao ST. Management of Brain Metastasis in Patients With Pulmonary Neuroendocrine Carcinomas. Technol Cancer Res Treat. 2015 Jun 3. doi:pii: 1533034615589033. [Epub ahead of print] PMID:26041398

Kovac E, Stephenson AJ. Management of Stage I Nonseminomatous Germ Cell Tumors. Urol Clin North Am. 2015 Aug;42(3):299-310. doi: 10.1016/j.ucl.2015.04.004. Review. PMID:26216817

Koyfman SA, Shukla ME, Bricker A, Djemil T, Wood B, Masaryk T, Suh JH. Stereotactic body radiotherapy for a large arteriovenous malformation of the head and neck. Laryngoscope. 2015. 125(2):379-82.

Krishnamurthy N, Liu L, Xiong X, Zhang J, Montano MM. Downregulation of hPMC2 imparts chemotherapeutic sensitivity to alkylating agents in breast cancer cells. Cancer Biol Ther. 2015 Apr 7:1-10. [Epub ahead of print] PMID:25849309

Kshettry VR, Hsieh JK, Ostrom QT, Kruchko C, Benzel EC, Barnholtz-Sloan JS. Descriptive Epidemiology of Spinal Meningiomas in the United States. Spine (Phila Pa 1976). 2015 May 20. [Epub ahead of print] PMID:25996535

Kshettry VR, Ostrom QT, Kruchko C, Al-Mefty O, Barnett GH, Barnholtz-Sloan JS. Descriptive epidemiology of World Health Organization grades II and III intracranial meningiomas in the United States. Neuro Oncol. 2015 May 24. doi:pii: nov069. [Epub ahead of print] PMID:26008603

Kuchenbaecker KB, Ramus SJ, Tyrer J, Lee A, Shen HC, Beesley J, Lawrenson K, McGuffog L, Healey S, Lee JM, Spindler TJ, Lin YG, Pejovic T, Bean Y, Li Q, Coetzee S, Hazelett D, Miron A, Southey M, Terry MB, Goldgar DE, Buys SS, et al. Identification of six new susceptibility loci for invasive epithelial ovarian cancer. Nat Genet. 2015 Feb;47(2):164-71. doi: 10.1038/ng.3185. Epub 2015 Jan 12. PMID:25581431

Kundu N, Chopra K, Morales R, Djohan R, Chung T, Gastman BR. Superior epigastric artery perforator (SEAP) flap: A novel approach to autologous breast reconstruction. J Plast Reconstr Aesthet Surg. 2015 Apr;68(4):519-24. doi: 10.1016/j.bjps.2014.12.006. Epub 2014 Dec 18. PMID:25582506

Kurtovic-Kozaric A, Przychodzen B, Singh J, Konarska MM, Clemente MJ, Otrock ZK, Nakashima M, Hsi ED, Yoshida K, Shiraishi Y, Chiba K, Tanaka H, Miyano S, Ogawa S, Boultwood J, Makishima H, Maciejewski JP, Padgett RA. PRPF8 defects cause missplicing in myeloid malignancies. Leukemia. 2015. 29(1):126-36. PMCID: PMC4214909

Kwon H, Kim KS, Chun YM, Wu HG, Carlson JN, Park JM, Kim JI. Evaluation of a commercial orthopaedic metal artefact reduction tool in radiation therapy of patients with head and neck cancer. Br J Radiol. 2015 Jun 17:20140536. [Epub ahead of print] PMID:25993487

Kypriotakis G, Vidrine DJ, Francis LE, Rose JH. The longitudinal relationship between quality of life and survival in advanced stage cancer. Psychooncology. 2015 May 8. doi: 10.1002/pon.3846. [Epub ahead of print] PMID:25959260

Kypriotakis G, Vidrine DJ, Francis LE, Rose JH. The longitudinal relationship between quality of life and survival in advanced stage cancer. Psychooncology. 2015 May 8. doi: 10.1002/pon.3846. [Epub ahead of print] PMID:25959260

Kyriakopoulos CE, Chittoria N, Choueiri TK, Kroeger N, Lee JL, Srinivas S, Knox JJ, Bjarnason GA, Ernst SD, Wood LA, Vaishampayan UN, Agarwal N, Pal SK, Kanesvaran R, Rha SY, Yuasa T, Donskov F, North SA, Heng DY, Rini BI. Outcome of patients with metastatic sarcomatoid renal cell carcinoma: results from the international metastatic renal cell carcinoma database consortium. Clin Genitourin Cancer. 2015 Apr;13(2):e79-85. doi: 10.1016/j.clgc.2014.08.011. Epub 2014 Sep 23. PMID:25450036

Lafata JE, Wunderlich T, Flocke SA, Oja-Tebbe N, Dyer KE, Siminoff LA. Physician use of persuasion and colorectal cancer screening. Transl Behav Med. 2015 Mar;5(1):87-93. doi: 10.1007/s13142-014-0284-x. PMID:25729457 | PMCID:PMC4332902

Lam E, Choi SH, Pareek TK, Kim BG, Letterio JJ. Cyclin-dependent kinase 5 represses Foxp3 gene expression and Treg development through specific phosphorylation of Stat3 at Serine 727. Mol Immunol. 2015 Jul 18. doi:pii: S0161-5890(15)00439-3.  10.1016/j.molimm.2015.06.015. [Epub ahead of print] PMID:26198700

Lam E, Pareek TK, Letterio JJ. Cdk5 controls IL-2 gene expression via repression of the mSin3a-HDAC complex. Cell Cycle. 2015 Apr 18;14(8):1327-36. doi: 10.4161/15384101.2014.987621. PMID:25785643

Lane BR, Derweesh IH, Kim HL, O__Malley R, Klink J, Ercole CE, Palazzi KL, Thomas AA, Rini BI, Campbell SC. Presurgical sunitinib reduces tumor size and may facilitate partial nephrectomy in patients with renal cell carcinoma. Urol Oncol. 2015 Mar;33(3):112.e15-112.e21. doi: 10.1016/j.urolonc.2014.11.009. Epub 2014 Dec 19. PMID:25532471

Lau JE, Weber C, Earl M, Rybicki LA, Carlstrom KD, Wenzell CM, Hill BT, Majhail NS, Kalaycio M. Outcomes after autologous SCT in lymphoma patients grouped by weight. Bone Marrow Transplant. 2015 Feb 9. doi: 10.1038/bmt.2014.327. [Epub ahead of print] PMID:25665041

Lee BH, Kibel AS, Ciezki JP, Klein EA, Reddy CA, Yu C, Kattan MW, Stephenson AJ. Are Biochemical Recurrence Outcomes Similar After Radical Prostatectomy and Radiation Therapy? Analysis of Prostate Cancer-Specific Mortality by Nomogram-predicted Risks of Biochemical Recurrence. Eur Urol. 2015 Feb;67(2):204-9. doi: 10.1016/j.eururo.2014.09.017. Epub 2014 Oct 5. PMID:25294696

Lee G, Singanamalli A, Wang H, Feldman M, Master S, Shih N, Spangler E, Rebbeck T, Tomaszewski J, Madabhushi A. Supervised Multi-View Canonical Correlation Analysis (sMVCCA): Integrating histologic and proteomic features for predicting recurrent prostate cancer. IEEE Trans Med Imaging. 2015. 34(1):284-97.

Leech M, Morris L, Stewart M, Smith BD, Bashey A, Holland K, Solomon S, Zhang X, Carraway HE, Pratz K, Gore SD, Zeidan AM. Real-life experience of a brief arsenic trioxide-based consolidation chemotherapy in the management of acute promyelocytic leukemia: favorable outcomes with limited anthracycline exposure and shorter consolidation therapy. Clin Lymphoma Myeloma Leuk. 2015 May;15(5):292-7. doi: 10.1016/j.clml.2014.11.001. Epub 2014 Nov 15. PMID:25499624

Li B. DNA Double-Strand Breaks and Telomeres Play Important Roles in Trypanosoma brucei Antigenic Variation. Eukaryot Cell. 2015. In Press

Li W, Wang QL, Liu X, Dong SH, Li HX, Li CY, Guo LS, Gao JM, Berger NA, Li L, Ma L, Wu YJ. Combined use of vitamin D3 and metformin exhibits synergistic chemopreventive effects on colorectal neoplasia in rats and mice. Cancer Prev Res (Phila). 2015 Feb;8(2):139-48. doi: 10.1158/1940-6207.CAPR-14-0128. Epub 2014 Nov 21. PMID:25416412

Li Z, Bishop AC, Alyamani M, Garcia JA, Dreicer R, Bunch D, Liu J, Upadhyay SK, Auchus RJ, Sharifi N. Conversion of abiraterone to D4A drives anti-tumour activity in prostate cancer. Nature. 2015 Jun 1. doi: 10.1038/nature14406. [Epub ahead of print] PMID:26030522

Li Z, Bishop AC, Alyamani M, Garcia JA, Dreicer R, Bunch D, Liu J, Upadhyay SK, Auchus RJ, Sharifi N. Conversion of abiraterone to D4A drives anti-tumour activity in prostate cancer. Nature. 2015 Jul 16;523(7560):347-51. doi: 10.1038/nature14406. Epub 2015 Jun 1. PMID:26030522 | PMCID:PMC4506215

Litjens GJ, Elliott R, Shih NN, Feldman MD, Kobus T, Hulsbergen-van de Kaa C, Barentsz JO, Huisman HJ, Madabhushi A. Computer-extracted Features Can Distinguish Noncancerous Confounding Disease from Prostatic Adenocarcinoma at Multiparametric MR Imaging. Radiology. 2015 Jul 17:142856. [Epub ahead of print] PMID:26192734

Liu JC, Ridge JA, Brizel DM, O'Sullivan B, Cohen EW, Mann BS, Adelstein DJ. Current Status of Clinical Trials in Head and Neck Cancer 2014. Otolaryngol Head Neck Surg. 2015 Mar;152(3):410-417. Epub 2015 Jan 20. Review. PMID:25605695

Liu Z, Xu-Monette ZY, Cao X, Manyam GC, Wang X, Tzankov A, Xia Y, Li X, Visco C, Sun R, Zhang L, Montes-Moreno S, DybkÌ_r K, Chiu A, Orazi A, Zu Y, Bhagat G, Richards KL, Hsi ED, Choi WW, van Krieken JH, Huh J, et al. Prognostic and biological significance of survivin expression in patients with diffuse large B-cell lymphoma treated with rituximab-CHOP therapy. Mod Pathol. 2015 Aug 7. doi: 10.1038/modpathol.2015.94. [Epub ahead of print] PMID:26248897

Lo SS, Ryu S, Chang EL, Galanopoulos N, Jones J, Kim EY, Kubicky CD, Lee CP, Rose PS, Sahgal A, Sloan AE, Teh BS, Traughber BJ, Van Poznak C, Vassil AD. ACR Appropriateness Criteria(ÎÂ) Metastatic Epidural Spinal Cord Compression and Recurrent Spinal Metastasis. J Palliat Med. 2015 Jul;18(7):573-84. doi: 10.1089/jpm.2015.28999.sml. Epub 2015 May 14. PMID:25974663

Loughran TP Jr, Zickl L, Olson TL, Wang V, Zhang D, Rajala HL, Hasanali Z, Bennett JM, Lazarus HM, Litzow MR, Evens AM, Mustjoki S, Tallman MS. Immunosuppressive therapy of LGL leukemia: prospective multicenter phase II study by the Eastern Cooperative Oncology Group (E5998). Leukemia. 2015 Apr;29(4):886-94. doi: 10.1038/leu.2014.298. Epub 2014 Sep 13. PMID:25306898 | PMCID:PMC4377298

Lu S, Morris VB, Labhasetwar V. Codelivery of DNA and siRNA via arginine-rich PEI-based polyplexes. Mol Pharm. 2015 Feb 2;12(2):621-9. doi: 10.1021/mp5006883. Epub 2015 Jan 15. PMID:25591125 | PMCID:PMC4314506

Lukenbill J, Hill B. Relapsed/refractory diffuse large B-cell lymphoma: review of the management of transplant-eligible patients. Leuk Lymphoma. 2015 Feb;56(2):293-300. doi: 10.3109/10428194.2014.910660. Epub 2014 Jun 16. PMID:24813764

Lym RL, Ostrom QT, Kruchko C, Couce M, Brat DJ, Louis DN, Barnholtz-Sloan JS. Completeness and concordancy of WHO grade assignment for brain and central nervous system tumors in the United States, 2004-2011. J Neurooncol. 2015 Apr 12. [Epub ahead of print] PMID:25864099

Lyman GH, Bohlke K, Khorana AA, Kuderer NM, Lee AY, Arcelus JI, Balaban EP, Clarke JM, Flowers CR, Francis CW, Gates LE, Kakkar AK, Key NS, Levine MN, Liebman HA, Tempero MA, Wong SL, Somerfield MR, Falanga A; American Society of Clinical Oncology. Venous thromboembolism prophylaxis and treatment in patients with cancer: american society of clinical oncology clinical practice guideline update 2014. J Clin Oncol. 2015 Feb 20;33(6):654-6. doi: 10.1200/JCO.2014.59.7351. Epub 2015 Jan 20. PMID:25605844

Mace AG, Pai RK, Stocchi L, Kalady MF. American joint committee on cancer and college of american pathologists regression grade: a new prognostic factor in rectal cancer. Dis Colon Rectum. 2015. 58(1):32-44.

Mahal BA, Chen MH, Bennett CL, Kattan MW, Sartor O, Stein K, D'Amico AV, Nguyen PL. High PSA anxiety and low health literacy skills: drivers of early use of salvage ADT among men with biochemically recurrent prostate cancer after radiotherapy? Ann Oncol. 2015 Jul;26(7):1390-5. doi: 10.1093/annonc/mdv185. Epub 2015 Apr 28. PMID:25926039 | PMCID:PMC4478973

Mahal BA, Chen MH, Bennett CL, Kattan MW, Sartor O, Stein K, D'Amico AV, Nguyen PL. The association between race and treatment regret among men with recurrent prostate cancer. Prostate Cancer Prostatic Dis. 2015 Mar;18(1):38-42. doi: 10.1038/pcan.2014.42. Epub 2014 Oct 28. PMID:25348256

Mahdi H, Gockley A, Esselen K, Marquard J, Nutter B, Yang B, Hinchcliff E, Horowitz N, Rose PG. Outcome of neoadjuvant chemotherapy in BRCA1/2 mutation positive women with advanced stage MÌ_llerian cancer. Gynecol Oncol. 2015 Jul 22. doi:pii: S0090-8258(15)30086-X.  10.1016/j.ygyno.2015.07.101. [Epub ahead of print] PMID:26210778

Mahdi H, Jernigan A, Nutter B, Michener C, Rose PG. Lymph node metastasis and pattern of recurrence in clinically early stage endometrial cancer with positive lymphovascular space invasion. J Gynecol Oncol. 2015 Jul;26(3):208-13. doi: 10.3802/jgo.2015.26.3.208. Epub 2015 Jan 26. PMID:25686395 | PMCID:PMC4510337

Mahdi H, Maurer KA, Nutter B, Rose PG. The Impact of Percent Reduction in CA-125 Levels on Prediction of the Extent of Interval Cytoreduction and Outcome in Patients With Advanced-Stage Cancer of M’_llerian Origin Treated With Neoadjuvant Chemotherapy. Int J Gynecol Cancer. 2015 Jun;25(5):823-9. doi: 10.1097/IGC.0000000000000434. PMID:25828750

Mahdi H, Mester JL, Nizialek EA, Ngeow J, Michener C, Eng C. Germline PTEN, SDHB-D, and KLLN alterations in endometrial cancer patients with Cowden and Cowden-like syndromes: an international, multicenter, prospective study. Cancer. 2015 Mar 1;121(5):688-96. doi: 10.1002/cncr.29106. Epub 2014 Nov 5. PMID:25376524 | PMCID:PMC4339629

Mahdi H, Rizzo A, Rose PG. Outcome of recurrent uterine papillary serous carcinoma treated with platinum-based chemotherapy. Int J Gynecol Cancer. 2015 Mar;25(3):467-73. doi: 10.1097/IGC.0000000000000382. PMID:25695549

Mahdi H, Wiechert A, Lockhart D, Rose PG. Impact of Age on 30-Day Mortality and Morbidity in Patients Undergoing Surgery for Ovarian Cancer. Int J Gynecol Cancer. 2015 Jun 12. [Epub ahead of print] PMID:26076218

Malamas AS, Jin E, Zhang Q, Haaga J, Lu ZR. Anti-angiogenic Effects of Bumetanide Revealed by DCE-MRI with a Biodegradable Macromolecular Contrast Agent in a Colon Cancer Model. Pharm Res. 2015 Apr 4. [Epub ahead of print] PMID:25840948

Man J, Shoemake JD, Ma T, Rizzo AE, Godley AR, Wu Q, Mohammadi AM, Bao S, Rich JN, Yu JS. Hyperthermia Sensitizes Glioma Stem-like Cells to Radiation by Inhibiting AKT Signaling. Cancer Res. 2015 Apr 15;75(8):1760-9. doi: 10.1158/0008-5472.CAN-14-3621. Epub 2015 Feb 20. PMID:25712125 | PMCID:PMC4401644

Mathew LK, Huangyang P, Mucaj V, Lee SS, Skuli N, Eisinger-Mathason TS, Biju K, Li B, Venneti S, Lal P, Lathia JD, Rich JN, Keith B, Simon MC. Feedback circuitry between miR-218 repression and RTK activation in glioblastoma. Sci Signal. 2015 May 5;8(375):ra42. doi: 10.1126/scisignal.2005978. PMID:25943352 | PMCID:PMC4437515

Mayer EL, Gropper AB, Harris L, Gold JM, Parker L, Kuter I, Come S, Najita JS, Guo H, Winer EP, Burstein HJ. Long-Term Follow-Up After Preoperative Trastuzumab and Chemotherapy for HER2-Overexpressing Breast Cancer. Clin Breast Cancer. 2015. 15(1):24-30

Maywald RL, Doerner SK, Pastorelli L, De Salvo C, Benton SM, Dawson EP, Lanza DG, Berger NA, Markowitz SD, Lenz HJ, Nadeau JH, Pizarro TT, Heaney JD. IL-33 activates tumor stroma to promote intestinal polyposis. Proc Natl Acad Sci U S A. 2015 May 12;112(19):E2487-96. doi: 10.1073/pnas.1422445112. Epub 2015 Apr 27. PMID:25918379 | PMCID:PMC4434739

Maziarz RT, Devos T, Bachier CR, Goldstein SC, Leis JF, Devine SM, Meyers G, Gajewski JL, Maertens J, Deans RJ, Van't Hof W, Lazarus HM. Single and Multiple Dose MultiStem (Multipotent Adult Progenitor Cell) Therapy Prophylaxis of Acute Graft-versus-Host Disease in Myeloablative Allogeneic Hematopoietic Cell Transplantation: A Phase 1 Trial. Biol Blood Marrow Transplant. 2015 Apr;21(4):720-8. doi: 10.1016/j.bbmt.2014.12.025. Epub 2014 Dec 30. PMID:25555450

McGraw KL, Zhang LM, Rollison DE, Basiorka AA, Fulp W, Rawal B, Jerez A, Billingsley DL, Lin HY, Kurtin SE, Yoder S, Zhang Y, Guinta K, Mallo M, Solê F, Calasanz MJ, Cervera J, Such E, Gonzêlez T, Nevill TJ, Haferlach T, Smith AE, et al. The relationship of TP53 R72P polymorphism to disease outcome and TP53 mutation in myelodysplastic syndromes. Blood Cancer J. 2015 Mar 13;5:e291. doi: 10.1038/bcj.2015.11. PMID:25768405 | PMCID:PMC4382654

Meeske KA, Ji L, Freyer DR, Gaynon P, Ruccione K, Butturini A, Avramis VI, Siegel S, Matloub Y, Seibel NL, Sposto R. Comparative toxicity by sex among children treated for acute lymphoblastic leukemia: A report from the Children's oncology group. Pediatr Blood Cancer. 2015 Jul 14. doi: 10.1002/pbc.25628. [Epub ahead of print] PMID:26173904

Mei Q, Chen M, Lu X, Li X, Duan F, Wang M, Luo G, Han W. An open-label, single-arm, phase I/II study of lower-dose decitabine based therapy in patients with advanced hepatocellular carcinoma. Oncotarget. 2015 Mar 29. [Epub ahead of print] PMID:25895027

Meropol N Efficacy Endpoints of Radiation Therapy Group Protocol 0247: A Randomized, Phase 2 Study of Neoadjuvant Radiation Therapy Plus Concurrent Capecitabine and Irinotecan or Capecitabine and Oxaliplatin for Patients With Locally Advanced Rectal Cancer Red Journal. 2015. In Press

Merry CR, McMahon S, Thompson CL, Miskimen KL, Harris LN, Khalil AM. Integrative transcriptome-wide analyses reveal critical HER2-regulated mRNAs and lincRNAs in HER2+ breast cancer. Breast Cancer Res Treat. 2015 Apr;150(2):321-34. doi: 10.1007/s10549-015-3327-1. Epub 2015 Mar 8. PMID:25749757

Mikulski Z, Johnson R, Shaked I, Kim G, Nowyhed H, Goodman W, Chodaczek G, Pizarro TT, Cominelli F, Ley K. SAMP1/YitFc Mice Develop Ileitis via Loss of CCL21 and Defects in Dendritic Cell Migration. Gastroenterology. 2015. In Press

Miller K, Harrington SM, Procop GW. Acid-fast Smear and Histopathology Results Provide Guidance for the Appropriate Use of Broad-Range Polymerase Chain Reaction and Sequencing for Mycobacteria. Arch Pathol Lab Med. 2015. In Press

Misra S, Hascall VC, Markwald RR, Ghatak S. Interactions between Hyaluronan and Its Receptors (CD44, RHAMM) Regulate the Activities of Inflammation and Cancer. Front Immunol. 2015;6:201. doi: 10.3389/fimmu.2015.00201. Review. PMID:25999946 | PMCID:PMC4422082

Moayyedi P, Weinberg DS, Schê_nemann H, Chak A. Management of pancreatic cysts in an evidence-based world. Gastroenterology. 2015 Apr;148(4):692-5. doi: 10.1053/j.gastro.2015.02.035. Epub 2015 Feb 24. No abstract available. PMID:25724461

Molenaar RJ, Thota S, Nagata Y, Patel B, Clemente M, Hirsh C, Viny AD, Hosano N, Bleeker FE, Meggendorfer M, Alpermann T, Shiraishi Y, Chiba K, Tanaka H, van Noorden CJ, Radivoyevitch T, Carraway H, Makishima H, Miyano S, Sekeres MA, Ogawa S, Haferlach T, Clinical and biological implications of ancestral and non-ancestral IDH1 and IDH2 mutations in myeloid neoplasms. Leukemia. 2015 Apr 3. doi: 10.1038/leu.2015.91. [Epub ahead of print] PMID:25836588

Montero AJ. Guidelines are essential to improving clinical outcomes in breast cancer patients. Breast Cancer Res Treat. 2015 Aug 6. [Epub ahead of print] No abstract available. PMID:26245162

Morais CL, Han JS, Gordetsky J, Nagar MS, Anderson AE, Lee S, Hicks JL, Zhou M, Magi-Galluzzi C, Shah RB, Epstein JI, De Marzo AM, Lotan TL. Utility of PTEN and ERG immunostaining for distinguishing high-grade PIN from intraductal carcinoma of the prostate on needle biopsy. Am J Surg Pathol. 2015 Feb;39(2):169-78. doi: 10.1097/PAS.0000000000000348. PMID:25517949 | PMCID:PMC4293206

Morrison CD, Schiemann WP. Tipping the balance between good and evil: aberrant 14-3-3ë¦ expression drives oncogenic TGF-ë_ signaling in metastatic breast cancers. Breast Cancer Res. 2015 Jul 11;17:92. doi: 10.1186/s13058-015-0603-2. PMID:26160166

Mukherjee S, Boccaccio D, Sekeres MA, Copelan E. Allogeneic hematopoietic cell transplantation for myelodysplastic syndromes: lingering uncertainties and emerging possibilities. Biol Blood Marrow Transplant. 2015 Mar;21(3):412-20. doi: 10.1016/j.bbmt.2014.07.027. Epub 2014 Jul 29. Review. PMID:25079875

Nagaraj AB, Joseph P, Kovalenko O, Singh S, Armstrong A, Redline R, Resnick K, Zanotti K, Waggoner S, DiFeo A. Critical role of Wnt/ë_-catenin signaling in driving epithelial ovarian cancer platinum resistance. Oncotarget. 2015 Jun 29. [Epub ahead of print] PMID:26125441

Naik M, Ward MC, Bledsoe TJ, Kumar AM, Rybicki LA, Saxton JP, Burkey BB, Greskovich JF, Adelstein DJ, Koyfman SA. It is not just IMRT: Human papillomavirus related oropharynx squamous cell carcinoma is associated with better swallowing outcomes after definitive chemoradiotherapy. Oral Oncol. 2015 May 11. doi:pii: S1368-8375(15)00183-9.  10.1016/j.oraloncology.2015.04.008. [Epub ahead of print] PMID:25977228

Nawrocki ST, Kelly KR, Smith PG, Keaton M, Carraway H, Sekeres MA, Maciejewski JP, Carew JS. The NEDD8-Activating Enzyme Inhibitor MLN4924 Disrupts Nucleotide Metabolism and Augments the Efficacy of Cytarabine. Clin Cancer Res. 2015. 21(2):439-47. PMCID:PMC4297545

Nazha A, Sekeres MA, Gore SD, Zeidan AM. Molecular Testing in Myelodysplastic Syndromes for the Practicing Oncologist: Will the Progress Fulfill the Promise? Oncologist. 2015 Jul 20. doi:pii: theoncologist.2015-0067. [Epub ahead of print] PMID:26194858

Ngeow J, Eng C. New Genetic and Genomic Approaches in the Post-GWAS Era - Back to the Future. Gastroenterology. 2015 Jun 11. doi:pii: S0016-5085(15)00823-9.  10.1053/j.gastro.2015.05.060. [Epub ahead of print] PMID:26073374

Ngeow J, Eng C. PTEN hamartoma tumor syndrome: Clinical risk assessment and management protocol. Methods. 2015 May;77-78:11-9. doi: 10.1016/j.ymeth.2014.10.011. Epub 2014 Oct 22. PMID:25461771

Ngeow J, Liu C, Zhou K, Frick KD, Matchar DB, Eng C. Detecting Germline PTEN Mutations Among At-Risk Patients With Cancer: An Age- and Sex-Specific Cost-Effectiveness Analysis. J Clin Oncol. 2015 Aug 10;33(23):2537-44. doi: 10.1200/JCO.2014.60.3456. Epub 2015 Jul 13. PMID:26169622

Ngeow J, Yu W, Yehia L, Niazi F, Chen J, Tang X, Heald B, Lei J, Romigh T, Tucker-Kellogg L, Lim KH, Song H, Eng C. Exome Sequencing Reveals Germline SMAD9 Mutation that Reduces PTEN Expression and is Associated with Hamartomatous Polyposis and Gastrointestinal Ganglioneuromas. Gastroenterology. 2015 Jun 26. doi:pii: S0016-5085(15)00886-0.  10.1053/j.gastro.2015.06.027. [Epub ahead of print] PMID:26122142

Ngo J, Matsuyama M, Kim C, Poventud-Fuentes I, Bates A, Siedlak SL, Lee HG, Doughman YQ, Watanabe M, Liner A, Hoit B, Voelkel N, Gerson S, Hasty P, Matsuyama S. Bax deficiency extends the survival of Ku70 knockout mice that develop lung and heart diseases. Cell Death Dis. 2015 Mar 26;6:e1706. doi: 10.1038/cddis.2015.11. PMID:25811803 | PMCID:PMC4385910

Ni Y, Seballos S, Ganapathi S, Gurin D, Fletcher B, Ngeow J, Nagy R, Kloos RT, Ringel MD, LaFramboise T, Eng C. Germline and somatic SDHx alterations in apparently sporadic differentiated thyroid cancer. Endocr Relat Cancer. 2015 Apr;22(2):121-30. doi: 10.1530/ERC-14-0537. PMID:25694510 | PMCID:PMC4335266

Nieboer D, Vergouwe Y, Roobol MJ, Ankerst DP, Kattan MW, Vickers AJ, Steyerberg EW; Prostate Biopsy Collaborative Group. Nonlinear modeling was applied thoughtfully for risk prediction: theÔ_Prostate Biopsy Collaborative Group. J Clin Epidemiol. 2015 Apr;68(4):426-34. doi: 10.1016/j.jclinepi.2014.11.022. Epub 2014 Nov 29. PMID:25777297

Nizialek EA, Mester JL, Dhiman VK, Smiraglia DJ, Eng C. KLLN epigenotype-phenotype associations in Cowden syndrome. Eur J Hum Genet. 2015 Feb 11. doi: 10.1038/ejhg.2015.8. [Epub ahead of print] PMID:25669429

O'Sullivan B, Adelstein DL, Huang SH, Koyfman SA, Thorstad W, Hope AJ, Lewis JS Jr, Nussenbaum B. First Site of Failure Analysis Incompletely Addresses Issues of Late and Unexpected Metastases in p16-Positive Oropharyngeal Cancer. J Clin Oncol. 2015 May 20;33(15):1707-8. doi: 10.1200/JCO.2014.58.2700. Epub 2015 Mar 30. No abstract available. PMID:25823739

Ochs-Balcom HM, Sun X, Chen Y, Barnholtz-Sloan J, Erwin DO, Jandorf L, Sucheston-Campbell L, Elston RC. Putative linkage signals identified for breast cancer in African American families. Cancer Epidemiol Biomarkers Prev. 2015 Feb;24(2):442-7. doi: 10.1158/1055-9965.EPI-14-1131. Epub 2014 Dec 4. PMID:25477366 | PMCID:PMC4323921

Ogden KM, Hu L, Jha BK, Sankaran B, Weiss SR, Silverman RH, Patton JT, Prasad BV. Structural basis for 2' -5' -oligoadenylate binding and enzyme activity of a viral RNase L antagonist. J Virol. 2015 Apr 15. doi:pii: JVI.00701-15. [Epub ahead of print] PMID:25878106

Ohri N, Duan F, Machtay M, Gorelick JJ, Snyder BS, Alavi A, Siegel BA, Johnson DW, Bradley JD, DeNittis A, Werner-Wasik M. Pretreatment FDG-PET metrics in stage III non-small cell lung cancer: ACRIN 6668/RTOG 0235. J Natl Cancer Inst. 2015 Feb 16;107(4). doi:pii: djv004.  10.1093/jnci/djv004. Print 2015 Apr. PMID:25688115

Oldenburg J, Aparicio J, Beyer J, Cohn-Cedermark G, Cullen M, Gilligan T, De Giorgi U, De Santis M, de Wit R, Fossê SD, Germê-Lluch JR, Gillessen S, Haugnes HS, Honecker F, Horwich A, Lorch A, Ondru D, Rosti G, Stephenson AJ, Tandstad T; On behalf of: Personalizing, not patronizing: the case for patient autonomy by unbiased presentation of management options in stage I testicular cancer. Ann Oncol. 2015 May;26(5):833-838. Epub 2014 Nov 6. Review. PMID:25378299

Olsson RF, Logan BR, Chaudhury S, Zhu X, Akpek G, Bolwell BJ, Bredeson CN, Dvorak CC, Gupta V, Ho VT, Lazarus HM, Marks DI, RingdÌn OT, Pasquini MC, Schriber JR, Cooke KR. Primary graft failure after myeloablative allogeneic hematopoietic cell transplantation for hematologic malignancies. Leukemia. 2015 Aug;29(8):1754-62. doi: 10.1038/leu.2015.75. Epub 2015 Mar 16. PMID:25772027 | PMCID:PMC4527886

Oran B, Jimenez AM, De Lima M, Popat UR, Bassett R, Andersson BS, Borthakur G, Bashir Q, Chen J, Ciurea SO, Jabbour E, Cortes J, Kebriaei P, Khouri IF, Qazilbash MH, Ravandi F, Rondon G, Lu X, Shpall EJ, Champlin RE. Age and Modified European LeukemiaNet Classification to Predict Transplant Outcomes: An Integrated Approach for Acute Myelogenous Leukemia Patients Undergoing Allogeneic Stem Cell Transplantation. Biol Blood Marrow Transplant. 2015 Aug;21(8):1405-12. doi: 10.1016/j.bbmt.2015.03.023. Epub 2015 Mar 31. PMID:25840338 | PMCID:PMC4506709

Ornstein MC, Mukherjee S, Keng M, Elson P, Tiu RV, Saunthararajah Y, Maggiotto A, Schaub M, Banks D, Advani A, Kalaycio M, Maciejewski JP, Sekeres MA. Impact of vancomycin-resistant enterococcal bacteremia on outcome during acute myeloid leukemia induction therapy. Leuk Lymphoma. 2015 Feb 20:1-7. [Epub ahead of print] PMID:25563427

Ornstein MC, Mukherjee S, Sekeres MA. More is better: combination therapies for myelodysplastic syndromes. Best Pract Res Clin Haematol. 2015 Mar;28(1):22-31. doi: 10.1016/j.beha.2014.11.002. Epub 2014 Nov 11. Review. PMID:25659727

Pai RK, Plesec TP, Abdul-Karim FW, Yang B, Marquard J, Shadrach B, Roma AR. Abrupt Loss of MLH1 and PMS2 Expression in Endometrial Carcinoma: Molecular and Morphologic Analysis of 6 Cases. Am J Surg Pathol. 2015 Jul;39(7):993-9. doi: 10.1097/PAS.0000000000000415. PMID:25786082

Pantuck AJ, Pettaway CA, Dreicer R, Corman J, Katz A, Ho A, Aronson W, Clark W, Simmons G, Heber D. A randomized, double-blind, placebo-controlled study of the effects of pomegranate extract on rising PSA levels in men following primary therapy for prostate cancer. Prostate Cancer Prostatic Dis. 2015 Jul 14. doi: 10.1038/pcan.2015.32. [Epub ahead of print] PMID:26169045

Parvani JG, Davuluri G, Wendt MK, Espinosa C, Tian M, Danielpour D, Sossey-Alaoui K, Schiemann WP. Deptor Enhances Triple-Negative Breast Cancer Metastasis and Chemoresistance through Coupling to Survivin Expression. Neoplasia. 2015 Mar;17(3):317-28. doi: 10.1016/j.neo.2015.02.003. PMID:25810016 | PMCID:PMC4372649

Parvani JG, Gujrati MD, Mack MA, Schiemann WP, Lu ZR. Silencing ï_3 Integrin by Targeted ECO/siRNA Nanoparticles Inhibits EMT and Metastasis of Triple-Negative Breast Cancer. Cancer Res. 2015 Jun 1;75(11):2316-25. doi: 10.1158/0008-5472.CAN-14-3485. Epub 2015 Apr 9. PMID:25858145 | PMCID:PMC4452414

Paspulati RM, Partovi S, Herrmann KA, Krishnamurthi S, Delaney CP, Nguyen NC. Comparison of hybrid FDG PET/MRI compared with PET/CT in colorectal cancer staging and restaging: a pilot study. Abdom Imaging. 2015 Aug;40(6):1415-25. doi: 10.1007/s00261-015-0474-0. PMID:26112492

Patel B, Hirsch C, Clemente M, Sekeres M, Makishima H, Maciejewski JP. Genetic and molecular characterization of myelodysplastic syndromes and related myeloid neoplasms. Int J Hematol. 2015 Mar;101(3):213-8. doi: 10.1007/s12185-015-1747-7. Epub 2015 Feb 18. PMID:25690487

Patil PA, Magi-Galluzzi C. MicroRNA in prostate cancer: Practical aspects. Histol Histopathol. 2015 Jul 17:11647. [Epub ahead of print] Review. PMID:26186079

Peiris PM, Abramowski A, Mcginnity J, Doolittle E, Toy R, Gopalakrishnan R, Shah S, Bauer L, Ghaghada KB, Hoimes C, Brady-Kalnay SM, Basilion JP, Griswold MA, Karathanasis E. Treatment of Invasive Brain Tumors Using a Chain-like Nanoparticle. Cancer Res. 2015 Apr 1;75(7):1356-65. doi: 10.1158/0008-5472.CAN-14-1540. Epub 2015 Jan 27. PMID:25627979 | PMCID:PMC4383708

Peiris PM, Deb P, Doolittle E, Doron G, Goldberg A, Govender P, Shah S, Rao S, Carbone S, Cotey T, Sylvestre M, Singh S, Schiemann WP, Lee Z, Karathanasis E. Vascular Targeting of a Gold Nanoparticle to Breast Cancer Metastasis. J Pharm Sci. 2015 Aug;104(8):2600-10. doi: 10.1002/jps.24518. Epub 2015 Jun 2. PMID:26036431 | PMCID:PMC4504827

Perera RH, Hernandez C, Zhou H, Kota P, Burke A, Exner AA. Ultrasound imaging beyond the vasculature with new generation contrast agents. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2015 Jul;7(4):593-608. doi: 10.1002/wnan.1326. Epub 2015 Jan 8. PMID:25580914 | PMCID:PMC4478095

Plecha D, Bai S, Patterson H, Thompson C, Shenk R. Improving the Accuracy of Axillary Lymph Node Surgery in Breast Cancer with Ultrasound-Guided Wire Localization of Biopsy Proven Metastatic Lymph Nodes. Ann Surg Oncol. 2015 Mar 27. [Epub ahead of print] PMID:25814365

Polprasert C, Schulze I, Sekeres MA, Makishima H, Przychodzen B, Hosono N, Singh J, Padgett RA, Gu X, Phillips JG, Clemente M, Parker Y, Lindner D, Dienes B, Jankowsky E, Saunthararajah Y, Du Y, Oakley K, Nguyen N, Mukherjee S, Pabst C, Godley LA, et al. Inherited and Somatic Defects in DDX41 in Myeloid Neoplasms. Cancer Cell. 2015 May 11;27(5):658-70. doi: 10.1016/j.ccell.2015.03.017. Epub 2015 Apr 23. PMID:25920683

Popat U, Mehta RS, Rezvani K, Fox P, Kondo K, Marin D, McNiece I, Oran B, Hosing C, Olson A, Parmar S, Shah N, Andreeff M, Kebriaei P, Kaur I, Yvon E, de Lima M, Cooper LJ, Tewari P, Champlin RE, Nieto Y, Andersson BS, et al. Enforced fucosylation of cord blood hematopoietic cells accelerates neutrophil and platelet engraftment after transplantation. Blood. 2015 May 7;125(19):2885-92. doi: 10.1182/blood-2015-01-607366. Epub 2015 Mar 16. PMID:25778529 | PMCID:PMC4424412

Pore D, Bodo J, Danda A, Yan D, Phillips JG, Lindner D, Hill BT, Smith MR, Hsi ED, Gupta N. Identification of Ezrin-Radixin-Moesin proteins as novel regulators of pathogenic B-cell receptor signaling and tumor growth in diffuse large B-cell lymphoma. Leukemia. 2015 Mar 24. doi: 10.1038/leu.2015.86. [Epub ahead of print] PMID:25801911

Porwal SK, Furia E, Harris ME, Viswanathan R, Devireddy L. Synthetic, potentiometric and spectroscopic studies of chelation between Fe(III) and 2,5-DHBA supports salicylate-mode of siderophore binding interactions. J Inorg Biochem. 2015 Apr;145:1-10. doi: 10.1016/j.jinorgbio.2014.12.010. Epub 2014 Dec 15. PMID:25589161

Puhalla S, Elmquist W, Freyer D, Kleinberg L, Adkins C, Lockman P, McGregor J, Muldoon L, Nesbit G, Peereboom D, Smith Q, Walker S, Neuwelt E. Unsanctifying the sanctuary: challenges and opportunities with brain metastases. Neuro Oncol. 2015 May;17(5):639-651. Review. PMID:25846288

Putnam AA, Gao Z, Liu F, Jia H, Yang Q, Jankowsky E. Division of Labor in an Oligomer of the DEAD-Box RNA Helicase Ded1p. Mol Cell. 2015 Jul 22. doi:pii: S1097-2765(15)00524-9.  10.1016/j.molcel.2015.06.030. [Epub ahead of print] PMID:26212457

Qin A, Thompson CL, Silverman P. Predictors of late-onset heart failure in breast cancer patients treated with doxorubicin. J Cancer Surviv. 2015 Jun;9(2):252-9. doi: 10.1007/s11764-014-0408-9. Epub 2014 Oct 24. PMID:25342090

Ratajczak MZ, Borkowska S, Mierzejewska K, Kucia M, Mendek-Czajkowska E, Suszynska M, Sharma VA, Deptala A, Song W, Platzbecker U, Larratt L, Janowska-Wieczorek A, Maciejewski J, Ratajczak J. Further evidence that paroxysmal nocturnal haemoglobinuria is a disorder of defective cell membrane lipid rafts. J Cell Mol Med. 2015 May 29. doi: 10.1111/jcmm.12605. [Epub ahead of print] PMID:26033571

Reichard CA, Stephenson AJ, Klein EA. Applying precision medicine to the active surveillance of prostate cancer. Cancer. 2015 Jul 6. doi: 10.1002/cncr.29496. [Epub ahead of print] PMID:26149066

Rini B, Goddard A, Knezevic D, Maddala T, Zhou M, Aydin H, Campbell S, Elson P, Koscielny S, Lopatin M, Svedman C, Martini JF, Williams JA, Verkarre V, Radulescu C, Neuzillet Y, Hemmerle I, Timsit MO, Tsiatis AC, Bonham M, Lebret T, Mejean A, et al. A 16-gene assay to predict recurrence after surgery in localised renal cell carcinoma: development and validation studies. Lancet Oncol. 2015 Jun;16(6):676-85. doi: 10.1016/S1470-2045(15)70167-1. Epub 2015 May 12. PMID:25979595

Rini BI, Melichar B, Fishman MN, Oya M, Pithavala YK, Chen Y, Bair AH, GrÌnwald V. Axitinib dose titration: analyses of exposure, blood pressure and clinical response from a randomized phase II study in metastatic renal cell carcinoma. Ann Oncol. 2015 Jul;26(7):1372-7. doi: 10.1093/annonc/mdv103. Epub 2015 Feb 20. PMID:25701454

Rini BI, Plimack ER, Takagi T, Elson P, Wood LS, Dreicer R, Gilligan T, Garcia J, Zhang Z, Kaouk J, Krishnamurthi V, Stephenson AJ, Fergany A, Klein EA, Uzzo RG, Chen DY, Campbell SC. A Phase II Study of Pazopanib in Patients with Localized Renal Cell Carcinoma to Optimize Preservation of Renal Parenchyma. J Urol. 2015 Aug;194(2):297-303. doi: 10.1016/j.juro.2015.03.096. Epub 2015 Mar 23. PMID:25813447

Rini BI, Quinn DI, Baum M, Wood LS, Tarazi J, Rosbrook B, Arruda LS, Cisar L, Roberts WG, Kim S, Motzer RJ. Hypertension among patients with renal cell carcinoma receiving axitinib or sorafenib: analysis from the randomized phase III AXIS trial. Target Oncol. 2015 Mar;10(1):45-53. doi: 10.1007/s11523-014-0307-z. Epub 2014 Mar 5. PMID:24595903 | PMCID:PMC4363524

Rini BI. Toward individualized treatment in urologic oncology. Urol Oncol. 2015 Feb 3. doi:pii: S1078-1439(14)00346-9.  10.1016/j.urolonc.2014.10.005. [Epub ahead of print] Review. No abstract available. PMID:25661236

Rivera M, Wu Q, Hamerlik P, Hjelmeland AB, Bao S, Rich JN. Acquisition of meiotic DNA repair regulators maintain genome stability in glioblastoma. Cell Death Dis. 2015 Apr 23;6:e1732. doi: 10.1038/cddis.2015.75. PMID:25906155

Rizvi NA, Maziêëres J, Planchard D, Stinchcombe TE, Dy GK, Antonia SJ, Horn L, Lena H, Minenza E, Mennecier B, Otterson GA, Campos LT, Gandara DR, Levy BP, Nair SG, Zalcman G, Wolf J, Souquet PJ, Baldini E, Cappuzzo F, Chouaid C, Dowlati A, et al. Activity and safety of nivolumab, an anti-PD-1 immune checkpoint inhibitor, for patients with advanced, refractory squamous non-small-cell lung cancer (CheckMate 063): a phase 2, single-arm trial. Lancet Oncol. 2015 Mar;16(3):257-65. doi: 10.1016/S1470-2045(15)70054-9. Epub 2015 Feb 20. PMID:25704439

Roach EC, Park MM, Tang WH, Thomas JD, Asosingh K, Kalaycio M, Erzurum SC, Farha S. Impaired right ventricular-pulmonary vascular function in myeloproliferative neoplasms. J Heart Lung Transplant. 2015 Mar;34(3):390-4. doi: 10.1016/j.healun.2014.09.009. Epub 2014 Sep 28. PMID:25638299 | PMCID:PMC4377111

Rollakanti KR, Anand S, Davis SC, Pogue BW, Maytin EV. Noninvasive Optical Imaging of UV-Induced Squamous Cell Carcinoma in Murine Skin: Studies of Early Tumor Development and Vitamin D Enhancement of Protoporphyrin IX Production. Photochem Photobiol. 2015 Jul 30. doi: 10.1111/php.12503. [Epub ahead of print] PMID:26223149

Rollakanti KR, Anand S, Maytin EV. Vitamin D enhances the efficacy of photodynamic therapy in a murine model of breast cancer. Cancer Med. 2015 Feb 25. doi: 10.1002/cam4.361. [Epub ahead of print] PMID:25712788

Rose JA, Erzurum S, Asosingh K. Biology and flow cytometry of proangiogenic hematopoietic progenitors cells. Cytometry A. 2015. 87(1):5-19.

Rose PG, Java J, Whitney CW, Stehman FB, Lanciano R, Thomas GM, DiSilvestro PA. Nomograms Predicting Progression-Free Survival, Overall Survival, and Pelvic Recurrence in Locally Advanced Cervical Cancer Developed From an Analysis of Identifiable Prognostic Factors in Patients From NRG Oncology/Gynecologic Oncology Group Randomized T J Clin Oncol. 2015 Jul 1;33(19):2136-42. doi: 10.1200/JCO.2014.57.7122. Epub 2015 Mar 2. PMID:25732170

Rothermundt C, Bailey A, Cerbone L, Eisen T, Escudier B, Gillessen S, GrÌnwald V, Larkin J, McDermott D, Oldenburg J, Porta C, Rini B, Schmidinger M, Sternberg C, Putora PM. Algorithms in the First-Line Treatment of Metastatic Clear Cell Renal Cell Carcinoma-Analysis Using Diagnostic Nodes. Oncologist. 2015 Aug 3. doi:pii: theoncologist.2015-0145. [Epub ahead of print] PMID:26240132

Rubin BP, Heinrich MC. Genotyping and immunohistochemistry of gastrointestinal stromal tumors: An update. Semin Diagn Pathol. 2015 Feb 7. doi:pii: S0740-2570(15)00018-0.  10.1053/j.semdp.2015.02.017. [Epub ahead of print] PMID:25766843

Saad F, Fizazi K, Jinga V, Efstathiou E, Fong PC, Hart LL, Jones R, McDermott R, Wirth M, Suzuki K, MacLean DB, Wang L, Akaza H, Nelson J, Scher HI, Dreicer R, Webb IJ, de Wit R; ELM-PC 4 investigators. Orteronel plus prednisone in patients with chemotherapy-naive metastatic castration-resistant prostate cancer (ELM-PC 4): a double-blind, multicentre, phase 3, randomised, placebo-controlled trial. Lancet Oncol. 2015 Mar;16(3):338-48. doi: 10.1016/S1470-2045(15)70027-6. Epub 2015 Feb 18. PMID:25701170

Sadraei NH, Dahiya S, Chao ST, Murphy ES, Osei-Boateng K, Xie H, Suh JH, Peereboom DM, Stevens GH, Ahluwalia MS. Treatment of cerebral radiation necrosis with bevacizumab: the cleveland clinic experience. Am J Clin Oncol. 2015 Jun;38(3):304-10. doi: 10.1097/COC.0b013e31829c3139. PMID:23799286

Sanchis-Gomar F, Lucia A, Yvert T, Ruiz-Casado A, Pareja-Galeano H, Santos-Lozano A, Fiuza-Luces C, Garatachea N, Lippi G, Bouchard C, Berger NA. Physical inactivity and low fitness deserve more attention to alter cancer risk and prognosis. Cancer Prev Res (Phila). 2015 Feb;8(2):105-10. doi: 10.1158/1940-6207.CAPR-14-0320. Epub 2014 Nov 21. PMID:25416409 | PMCID:PMC4315717

Satwani P, Ahn KW, Carreras J, Abdel-Azim H, Cairo MS, Cashen A, Chen AI, Cohen JB, Costa LJ, Dandoy C, Fenske TS, Freytes CO, Ganguly S, Gale RP, Ghosh N, Hertzberg MS, Hayashi RJ, Kamble RT, Kanate AS, Keating A, Kharfan-Dabaja MA, Lazarus HM, et al. A prognostic model predicting autologous transplantation outcomes in children, adolescents and young adults with Hodgkin lymphoma. Bone Marrow Transplant. 2015 Aug 3. doi: 10.1038/bmt.2015.177. [Epub ahead of print] PMID:26237164

Savona MR, Malcovati L, Komrokji R, Tiu RV, Mughal TI, Orazi A, Kiladjian JJ, Padron E, Solary E, Tibes R, Itzykson R, Cazzola M, Mesa R, Maciejewski J, Fenaux P, Garcia-Manero G, Gerds A, Sanz G, Niemeyer CM, Cervantes F, Germing U, Cross NC, et al. An international consortium proposal of uniform response criteria for myelodysplastic/myeloproliferative neoplasms (MDS/MPN) in adults. Blood. 2015 Mar 19;125(12):1857-65. doi: 10.1182/blood-2014-10-607341. Epub 2015 Jan 26. PMID:25624319

Schimelman JB, Dryden DM, Poudel L, Krawiec KE, Ma Y, Podgornik R, Parsegian VA, Denoyer LK, Ching WY, Steinmetz NF, French RH. Optical properties and electronic transitions of DNA oligonucleotides as a function of composition and stacking sequence. Phys Chem Chem Phys. 2015. In Press

Schneider JL, Davis J, Kauffman TL, Reiss JA, McGinley C, Arnold K, Zepp J, Gilmore M, Muessig KR, Syngal S, Acheson L, Wiesner GL, Peterson SK, Goddard KA. Stakeholder perspectives on implementing a universal Lynch syndrome screening program: a qualitative study of early barriers and facilitators. Genet Med. 2015 Apr 16. doi: 10.1038/gim.2015.43. [Epub ahead of print] PMID:25880440

Schnipper LE, Davidson NE, Wollins DS, Tyne C, Blayney DW, Blum D, Dicker AP, Ganz PA, Hoverman JR, Langdon R, Lyman GH, Meropol NJ, Mulvey T, Newcomer L, Peppercorn J, Polite B, Raghavan D, Rossi G, Saltz L, Schrag D, Smith TJ, Yu PP, et al. American Society of Clinical Oncology Statement: A Conceptual Framework to Assess the Value of Cancer Treatment Options. J Clin Oncol. 2015 Aug 10;33(23):2563-77. doi: 10.1200/JCO.2015.61.6706. Epub 2015 Jun 22. No abstract available. PMID:26101248

Schuster AT, Homer CR, Kemp JR, Nickerson KP, Deutschman E, Kim Y, West G, Sadler T, Stylianou E, Krokowski D, Hatzoglou M, de la Motte C, Rubin BP, Fiocchi C, McDonald C, Longworth MS. CAP-D3 Promotes Bacterial Clearance in Human Intestinal Epithelial Cells by Repressing Expression of Amino Acid Transporters. Gastroenterology. 2015 Feb 18. doi:pii: S0016-5085(15)00232-2.  10.1053/j.gastro.2015.02.013. [Epub ahead of print] PMID:25701737

Schuster AT, Homer CR, Kemp JR, Nickerson KP, Deutschman E, Kim Y, West G, Sadler T, Stylianou E, Krokowski D, Hatzoglou M, de la Motte C, Rubin BP, Fiocchi C, McDonald C, Longworth MS. Chromosome-associated protein d3 promotes bacterial clearance in human intestinal epithelial cells by repressing expression of amino Acid transporters. Gastroenterology. 2015 Jun;148(7):1405-1416.e3. doi: 10.1053/j.gastro.2015.02.013. Epub 2015 Feb 18. PMID:25701737 | PMCID:PMC4446190

Schuster J, Lai RK, Recht LD, Reardon DA, Paleologos NA, Groves MD, Mrugala MM, Jensen R, Baehring JM, Sloan A, Archer GE, Bigner DD, Cruickshank S, Green JA, Keler T, Davis TA, Heimberger AB, Sampson JH. A phase II, multicenter trial of rindopepimut (CDX-110) in newly diagnosed glioblastoma: the ACT III study. Neuro Oncol. 2015 Jun;17(6):854-61. doi: 10.1093/neuonc/nou348. Epub 2015 Jan 13. PMID:25586468

Seaberg B, Henslee G, Wang S, Paez-Colasante X, Landreth GE, Rimer M. Muscle-derived ERK1/2 MAP kinases are required for the maintenance of adult myofibers and their neuromuscular junctions. Mol Cell Biol. 2015. In Press

Seastone DJ, Gerds AT. Darbepoetin alfa for anemia with myelodysplastic syndrome. Expert Rev Hematol. 2015 Apr;8(2):139-46. doi: 10.1586/17474086.2015.1000854. Epub 2015 Jan 12. PMID:25579702

Sekeres MA, Gerds AT. Mitigating Fear and Loathing in Managing Acute Myeloid Leukemia. Semin Hematol. 2015 Jul;52(3):249-55. doi: 10.1053/j.seminhematol.2015.03.009. Epub 2015 Mar 17. Review. PMID:26111473

Sekeres MA, Gerds AT. The graceful exit or reluctant demise of the older adult with acute myeloid leukemia. Cancer. 2015 Aug 15;121(16):2678-80. doi: 10.1002/cncr.29428. Epub 2015 Apr 29. No abstract available. PMID:25926059

Shah N, Callander N, Ganguly S, Gul Z, Hamadani M, Costa L, Sengsayadeth S, Abidi M, Hari P, Mohty M, Chen YB, Koreth J, Landau H, Lazarus H, Leather H, Majhail N, Nath R, Osman K, Perales MA, Schriber J, Shaughnessy P, Vesole D, et al. Hematopoietic Stem Cell Transplantation for Multiple Myeloma: Guidelines from the American Society for Blood and Marrow Transplantation. Biol Blood Marrow Transplant. 2015 Jul;21(7):1155-1166. doi: 10.1016/j.bbmt.2015.03.002. Epub 2015 Mar 11. Review. PMID:25769794

Shah SN, Huang SS. Hybrid PET/MR imaging: physics and technical considerations. Abdom Imaging. 2015 Aug;40(6):1358-65. doi: 10.1007/s00261-015-0443-7. PMID:25985965

Sharifi N. Prostate cancer: CYP17A1 inhibitor failure-lessons for future drug development. Nat Rev Urol. 2015 Mar 31. doi: 10.1038/nrurol.2015.66. [Epub ahead of print] No abstract available. PMID:25823374

Sharifi N. Steroid sidestep: evading androgen ablation by abiraterone. Clin Cancer Res. 2015 Mar 15;21(6):1240-2. doi: 10.1158/1078-0432.CCR-14-2899. Epub 2014 Nov 28. PMID:25432158 | PMCID:PMC4359949

Sharma N, Zhang Z, Mir MC, Takagi T, Bullen J, Campbell SC, Remer EM. Comparison of 2 Computed Tomography-based Methods to Estimate Preoperative and Postoperative Renal Parenchymal Volume and Correlation With Functional Changes After Partial Nephrectomy. Urology. 2015 Jul;86(1):80-6. doi: 10.1016/j.urology.2015.04.029. PMID:26142589

Shaw BE, Logan BR, Kiefer DM, Chitphakdithai P, Pedersen TL, Abdel-Azim H, Abidi MH, Akpek G, Diaz MA, Artz AS, Dandoy C, Gajewski JL, Hematti P, Kamble RT, Kasow KA, Lazarus HM, Liesveld JL, Majhail NS, O'Donnell PV, Olsson RF, Savani BN, Schears RM, et Analysis of the Effect of Race, Socioeconomic Status, and Center Size on Unrelated National Marrow Donor Program Donor Outcomes: Donor Toxicities Are More Common at Low-Volume Bone Marrow Collection Centers. Biol Blood Marrow Transplant. 2015 Jun 23. doi:pii: S1083-8791(15)00415-2.  10.1016/j.bbmt.2015.06.013. [Epub ahead of print] PMID:26116089

Shenouda G, Zhang Q, Ang KK, Machtay M, Parliament MB, Hershock D, Suntharalingam M, Lin A, Rotman M, Nabid A, Hong S, Shehata S, Cmelak AJ, Sultanem K, Le QT. Long-term results of radiation therapy oncology group 9903: a randomized phase 3 trial to assess the effect of erythropoietin on local-regional control in anemic patients treated with radiation therapy for squamous cell carcinoma of the head and neck. Int J Radiat Oncol Biol Phys. 2015 Apr 1;91(5):907-15. doi: 10.1016/j.ijrobp.2014.12.018. Epub 2015 Feb 7. PMID:25670542

Shojania Feizabadi M, Janakaloti Narayanareddy BR, Vadpey O, Jun Y, Chapman D, Rosenfeld S, Gross SP. Microtubule C-Terminal Tails Can Change Characteristics of Motor Force Production. Traffic. 2015 Jun 22. doi: 10.1111/tra.12307. [Epub ahead of print] PMID:26094820

Shukla ME, Yu C, Reddy CA, Stephans KL, Klein EA, Abdel-Wahab M, Ciezki J, Tendulkar RD. Evaluation of the current prostate cancer staging system based on cancer-specific mortality in the surveillance, epidemiology, and end results database. Clin Genitourin Cancer. 2015 Feb;13(1):17-21. doi: 10.1016/j.clgc.2014.07.003. Epub 2014 Jul 14. PMID:25571871

Shukla S, Eber FJ, Nagarajan AS, DiFranco NA, Schmidt N, Wen AM, Eiben S, Twyman RM, Wege C, Steinmetz NF. The impact of aspect ratio on the biodistribution and tumor homing of rigid soft-matter nanorods. Adv Healthc Mater. 2015 Apr;4(6):874-82. doi: 10.1002/adhm.201400641. Epub 2015 Jan 13. PMID:25641794

Silver DJ, Sinyuk M, Vogelbaum MA, Ahluwalia MS, Lathia JD. The intersection of cancer, cancer stem cells, and the immune system: therapeutic opportunities. Neuro Oncol. 2015 Aug 11. doi:pii: nov157. [Epub ahead of print] Review. PMID:26264894

Silverman RH. Caps off to poxviruses. Cell Host Microbe. 2015 Mar 11;17(3):287-9. doi: 10.1016/j.chom.2015.02.013. PMID:25766288

Simper NB, Jones CL, MacLennan GT, Montironi R, Williamson SR, Osunkoya AO, Wang M, Zhang S, Grignon DJ, Eble JN, Tran T, Wang L, Baldrige LA, Cheng L. Basal cell carcinoma of the prostate is an aggressive tumor with frequent loss of PTEN expression and overexpression of EGFR. Hum Pathol. 2015 Feb 26. doi:pii: S0046-8177(15)00068-4.  10.1016/j.humpath.2015.02.004. [Epub ahead of print] PMID:25870120

Simpkins F, Drake R, Escobar PF, Nutter B, Rasool N, Rose PG. A phase II trial of paclitaxel, carboplatin, and bevacizumab in advanced and recurrent endometrial carcinoma (EMCA). Gynecol Oncol. 2015 Feb;136(2):240-5. doi: 10.1016/j.ygyno.2014.12.004. Epub 2014 Dec 6. PMID:25485782

Singanamalli A, Rusu M, Sparks RE, Shih NN, Ziober A, Wang LP, Tomaszewski J, Rosen M, Feldman M, Madabhushi A. Identifying in vivo DCE MRI markers associated with microvessel architecture and gleason grades of prostate cancer. J Magn Reson Imaging. 2015 Jun 25. doi: 10.1002/jmri.24975. [Epub ahead of print] PMID:26110513

Singh S, Shukla GC, Gupta S. MicroRNA Regulating Glutathione S-Transferase P1 in Prostate Cancer. Curr Pharmacol Rep. 2015 Apr 1;1(2):79-88. PMID:25774339 | PMCID:PMC4354897

Smith MR. Ibrutinib in B lymphoid malignancies. Expert Opin Pharmacother. 2015 Aug;16(12):1879-87. doi: 10.1517/14656566.2015.1067302. Epub 2015 Jul 13. PMID:26165513

Sobecks RM, Wang T, Askar M, Gallagher MM, Haagenson M, Spellman S, Fernandez-Vina M, Malmberg KJ, Miller C, Battiwalla M, Gajewski J, Verneris MR, Ringdon O, Marino S, Davies S, Dehn J, Bornhuser M, Inamoto Y, Woolfrey A, Shaw P, Pollack M, Weisdorf Impact of KIR and HLA Genotypes on Outcomes after Reduced-Intensity Conditioning Hematopoietic Cell Transplantation. Biol Blood Marrow Transplant. 2015 May 8. doi:pii: S1083-8791(15)00325-0.  10.1016/j.bbmt.2015.05.002. [Epub ahead of print] PMID:25960307

Sohal DP, Shrotriya S, Glass KT, Pelley RJ, McNamara MJ, Estfan B, Shapiro M, Wey J, Chalikonda S, Morris-Stiff G, Walsh RM, Khorana AA. Predicting early mortality in resectable pancreatic adenocarcinoma: A cohort study. Cancer. 2015 Jun 1;121(11):1779-84. doi: 10.1002/cncr.29298. Epub 2015 Feb 11. PMID:25676016

Sonpavde G, Pond GR, Rosenberg JE, Bajorin DF, Regazzi AM, Choueiri TK, Qu AQ, Niegisch G, Albers P, Necchi A, Di Lorenzo G, Fougeray R, Dreicer R, Chen YH, Wong YN, Sridhar SS, Ko YJ, Milowsky MI, Galsky MD, Bellmunt J. Complete Response as an Intermediate End Point in Patients Receiving Salvage Systemic Therapy forÔ_Urothelial Carcinoma. Clin Genitourin Cancer. 2015 Apr;13(2):185-92. doi: 10.1016/j.clgc.2014.09.004. Epub 2014 Oct 2. PMID:25458370

Sparks R, Bloch BN, Feleppa E, Barratt D, Moses D, Ponsky L, Madabhushi A. Multiattribute probabilistic prostate elastic registration (MAPPER): application to fusion of ultrasound and magnetic resonance imaging. Med Phys. 2015 Mar;42(3):1153-63. doi: 10.1118/1.4905104. PMID:25735270 | PMCID:PMC4327921

Steensma DP, Bejar R, Jaiswal S, Lindsley RC, Sekeres MA, Hasserjian RP, Ebert BL. Clonal hematopoiesis of indeterminate potential and its distinction from myelodysplastic syndromes. Blood. 2015 Jul 2;126(1):9-16. doi: 10.1182/blood-2015-03-631747. Epub 2015 Apr 30. PMID:25931582

Stetson LC, Pearl T, Chen Y, Barnholtz-Sloan JS. Erratum: Computational identification of multi-omic correlates of anticancer therapeutic response. BMC Genomics. 2015 Jun 30;16:481. doi: 10.1186/s12864-015-1630-1. No abstract available. PMID:26122008 | PMCID:PMC4484706

Stone RM, Mazzola E, Neuberg D, Allen SL, Pigneux A, Stuart RK, Wetzler M, Rizzieri D, Erba HP, Damon L, Jang JH, Tallman MS, Warzocha K, Masszi T, Sekeres MA, Egyed M, Horst HA, Selleslag D, Solomon SR, Venugopal P, Lundberg AS, Powell B. Phase III Open-Label Randomized Study of Cytarabine in Combination With Amonafide L-Malate or Daunorubicin As Induction Therapy for Patients With Secondary Acute Myeloid Leukemia. J Clin Oncol. 2015 Apr 10;33(11):1252-7. doi: 10.1200/JCO.2014.57.0952. Epub 2015 Mar 2. PMID:25732165

Su KH, Hu L, Stehning C, Helle M, Qian P, Thompson CL, Pereira GC, Jordan DW, Herrmann KA, Traughber M, Muzic RF Jr, Traughber BJ. Generation of brain pseudo-CTs using an undersampled, single-acquisition UTE-mDixon pulse sequence and unsupervised clustering. Med Phys. 2015 Aug;42(8):4974. doi: 10.1118/1.4926756. PMID:26233223

Sung PS, Cheon H, Cho CH, Hong SH, Park DY, Seo HI, Park SH, Yoon SK, Stark GR, Shin EC. Roles of unphosphorylated ISGF3 in HCV infection and interferon responsiveness. Proc Natl Acad Sci U S A. 2015 Jul 27. doi:pii: 201513341. [Epub ahead of print] PMID:26216956

Sutton J, Orloff MS, Michener C, Chiesa-Vottero A, Prayson R, Nowacki AS, Eng C. Association of specific PTEN/10q haplotypes with endometrial cancer phenotypes in African-American and European American women. Gynecol Oncol. 2015 May 28. doi:pii: S0090-8258(15)30006-8.  10.1016/j.ygyno.2015.05.024. [Epub ahead of print] PMID:26026735

Sutton J, Orloff MS, Michener C, Chiesa-Vottero A, Prayson R, Nowacki AS, Eng C. Association of specific PTEN/10q haplotypes with endometrial cancer phenotypes in African-American and European American women. Gynecol Oncol. 2015 Aug;138(2):434-40. doi: 10.1016/j.ygyno.2015.05.024. Epub 2015 May 28. PMID:26026735

Szulzewsky F, Pelz A, Feng X, Synowitz M, Markovic D, Langmann T, Holtman IR, Wang X, Eggen BJ, Boddeke HW, Hambardzumyan D, Wolf SA, Kettenmann H. Glioma-associated microglia/macrophages display an expression profile different from M1 and M2 polarization and highly express Gpnmb and Spp1. PLoS One. 2015;10(2):e0116644. doi: 10.1371/journal.pone.0116644. PMID:25658639 | PMCID:PMC4320099

Tanas MR, Ma S, Jadaan FO, Ng CK, Weigelt B, Reis-Filho JS, Rubin BP. Mechanism of action of a WWTR1(TAZ)-CAMTA1 fusion oncoprotein. Oncogene. 2015 May 11. doi: 10.1038/onc.2015.148. [Epub ahead of print] PMID:25961935

Thiagarajan PS, Hitomi M, Hale JS, Alvarado AG, Otvos B, Sinyuk M, Stoltz K, Wiechert A, Mulkearns-Hubert E, Jarrar AM, Zheng Q, Thomas D, Egelhoff TT, Rich JN, Liu H, Lathia JD, Reizes O. Development of a Fluorescent Reporter System to Delineate Cancer Stem Cells in Triple-Negative Breast Cancer. Stem Cells. 2015 Jul;33(7):2114-25. doi: 10.1002/stem.2021. Epub 2015 May 15. PMID:25827713 | PMCID:PMC4494654

Thomas DG, Yenepalli A, Denais CM, Rape A, Beach JR, Wang YL, Schiemann WP, Baskaran H, Lammerding J, Egelhoff TT. Non-muscle myosin IIB is critical for nuclear translocation during 3D invasion. J Cell Biol. 2015 Aug 10. doi:pii: jcb.201502039. [Epub ahead of print] PMID:26261182

Tilot AK, Bebek G, Niazi F, Altemus JB, Romigh T, Frazier TW, Eng C. Neural transcriptome of constitutional Pten dysfunction in mice and its relevance to human idiopathic autism spectrum disorder. Mol Psychiatry. 2015 Mar 10. doi: 10.1038/mp.2015.17. [Epub ahead of print] PMID:25754085

Tilot AK, Frazier TW 2nd, Eng C. Balancing Proliferation and Connectivity in PTEN-associated Autism Spectrum Disorder. Neurotherapeutics. 2015 Jul;12(3):609-19. doi: 10.1007/s13311-015-0356-8. PMID:25916396 | PMCID:PMC4489960

Toledo RA, Maciel RM, Erlic Z, Loureno DM Jr, Cerutti JM, Eng C, Neumann HP, Toledo SP. RET Y791F Variant Does Not Increase the Risk for Medullary Thyroid Carcinoma. Thyroid. 2015 Aug;25(8):973-4. doi: 10.1089/thy.2015.0168. Epub 2015 Jun 12. No abstract available. PMID:25950813

Tomlins SA, Alshalalfa M, Davicioni E, Erho N, Yousefi K, Zhao S, Haddad Z, Den RB, Dicker AP, Trock BJ, DeMarzo AM, Ross AE, Schaeffer EM, Klein EA, Magi-Galluzzi C, Karnes RJ, Jenkins RB, Feng FY. Characterization of 1577 Primary Prostate Cancers Reveals Novel Biological and Clinicopathologic Insights into Molecular Subtypes. Eur Urol. 2015 May 8. doi:pii: S0302-2838(15)00375-9.  10.1016/j.eururo.2015.04.033. [Epub ahead of print] PMID:25964175

Tonorezos ES, Stillwell EE, Calloway JJ, Glew T, Wessler JD, Rebolledo BJ, Pham A, Steingart RM, Lazarus H, Gale RP, Jakubowski AA, Schaffer WL. Arrhythmias in the setting of hematopoietic cell transplants. Bone Marrow Transplant. 2015 Jun 1. doi: 10.1038/bmt.2015.127. [Epub ahead of print] PMID:26030046

Trosman SJ, Koyfman SA, Ward MC, Al-Khudari S, Nwizu T, Greskovich JF, Lamarre ED, Scharpf J, Khan MJ, Lorenz RR, Adelstein DJ, Burkey BB. Effect of Human Papillomavirus on Patterns of Distant Metastatic Failure in Oropharyngeal Squamous Cell Carcinoma Treated With Chemoradiotherapy. JAMA Otolaryngol Head Neck Surg. 2015 Mar 5. doi: 10.1001/jamaoto.2015.136. [Epub ahead of print] PMID:25742025

Urbano-Ispizua A, Pavletic SZ, Flowers ME, Klein JP, Zhang MJ, Carreras J, Montoto S, Perales MA, Aljurf MD, Akpek G, Bredeson CN, Costa LJ, Dandoy C, Freytes CO, Fung HC, Gale RP, Gibson J, Hamadani M, Hayashi RJ, Inamoto Y, Inwards DJ, Lazarus HM, et al The Impact of Graft-versus-Host Disease on the Relapse Rate in Patients with Lymphoma Depends on the Histological Subtype and the Intensity of the Conditioning Regimen. Biol Blood Marrow Transplant. 2015 May 15. doi:pii: S1083-8791(15)00333-X.  10.1016/j.bbmt.2015.05.010. [Epub ahead of print] PMID:25981509

Vachani A, Pass HI, Rom WN, Midthun DE, Edell ES, Laviolette M, Li XJ, Fong PY, Hunsucker SW, Hayward C, Mazzone PJ, Madtes DK, Miller YE, Walker MG, Shi J, Kearney P, Fang KC, Massion PP. Validation of a multiprotein plasma classifier to identify benign lung nodules. J Thorac Oncol. 2015 Apr;10(4):629-37. doi: 10.1097/JTO.0000000000000447. PMID:25590604 | PMCID:PMC4382127

Van Poznak C, Harris LN, Somerfield MR. Use of Biomarkers to Guide Decisions on Systemic Therapy for Women With Metastatic Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline. J Oncol Pract. 2015 Jul 21. doi:pii: JOP.2015.005215. [Epub ahead of print] No abstract available. PMID:26199292

Van Poznak C, Somerfield MR, Bast RC, Cristofanilli M, Goetz MP, Gonzalez-Angulo AM, Hicks DG, Hill EG, Liu MC, Lucas W, Mayer IA, Mennel RG, Symmans WF, Hayes DF, Harris LN. Use of Biomarkers to Guide Decisions on Systemic Therapy for Women With Metastatic Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline. J Clin Oncol. 2015 Jul 20. doi:pii: JCO.2015.61.1459. [Epub ahead of print] PMID:26195705

Veta M, van Diest PJ, Willems SM, Wang H, Madabhushi A, Cruz-Roa A, Gonzalez F, Larsen AB, Vestergaard JS, Dahl AB, CireÈan DC, Schmidhuber J, Giusti A, Gambardella LM, Tek FB, Walter T, Wang CW, Kondo S, Matuszewski BJ, Precioso F, Snell V, Kittler J, e Assessment of algorithms for mitosis detection in breast cancer histopathology images. Med Image Anal. 2015 Feb;20(1):237-48. doi: 10.1016/ Epub 2014 Nov 29. PMID:25547073

Vij R, Kumar S, Zhang MJ, Zhong X, Huang J, Dispenzieri A, Abidi MH, Bird JM, Freytes CO, Gale RP, Kindwall-Keller TL, Kyle RA, Landsburg DJ, Lazarus HM, Munker R, Roy V, Sharma M, Vogl DT, Wirk B, Hari PN. Impact of Pretransplant Therapy and Depth of Disease Response before Autologous Transplantation for Multiple Myeloma. Biol Blood Marrow Transplant. 2015. 21(2):335-41. PMCID:PMC4297511

Virk SM, Gibson RM, Quinones-Mateu ME, Barnholtz-Sloan JS. Identification of variants in primary and recurrent glioblastoma using a cancer-specific gene panel and whole exome sequencing. PLoS One. 2015;10(5):e0124178. doi: 10.1371/journal.pone.0124178. PMID:25950952 | PMCID:PMC4423782

Visconte V, Avishai N, Mahfouz R, Tabarroki A, Cowen J, Sharghi-Moshtaghin R, Hitomi M, Rogers HJ, Hasrouni E, Phillips J, Sekeres MA, Heuer AH, Saunthararajah Y, Barnard J, Tiu RV. Distinct iron architecture in SF3B1 mutant myelodysplastic syndromes patients is linked to an SLC25A37 splice variant with a retained intron. Leukemia. 2015. 29(1):188-95.

Visconte V, Tabarroki A, Hasrouni E, Maciejewski JP, Hsi ED, Tiu RV, Rogers HJ. Molecular and phenotypic heterogeneity of refractory anemia with ring sideroblasts associated with marked thrombocytosis. Leuk Lymphoma. 2015 Jun 25:1-4. [Epub ahead of print] No abstract available. PMID:25926061

Vishwakarma BA, Nguyen N, Makishima H, Hosono N, Gudmundsson KO, Negi V, Oakley K, Han Y, Przychodzen B, Maciejewski JP, Du Y. Runx1 repression by histone deacetylation is critical for Setbp1-induced mouse myeloid leukemia development. Leukemia. 2015 Jul 24. doi: 10.1038/leu.2015.200. [Epub ahead of print] PMID:26205084

Vyas R, Gotow EK, DePry JL, Lazarus HM, Caimi PF, Bordeaux JS, Gerstenblith MR. Multiple skin cancers in a patient within 1 year of allogeneic haematopoietic cell transplant for chronic lymphocytic leukemia. Clin Exp Dermatol. 2015 Feb 13. doi: 10.1111/ced.12473. [Epub ahead of print] No abstract available. PMID:25683837

Wang C, Sen A, Plegue M, Ruffin MT 4th, O'Neill SM, Rubinstein WS, Acheson LS; Family Healthware Impact Trial (FHITr) Group; Family Healthware Impact Trial FHITr Group. Impact of Family History Assessment on Communication with Family Members and Health Care Providers: A report from the Family Healthware(TM) Impact Trial (FHITr). Prev Med. 2015 Aug;77:28-34. doi: 10.1016/j.ypmed.2015.04.007. Epub 2015 Apr 19. PMID:25901453 | PMCID:PMC4508012

Wang G, Weng YC, Han X, Whaley JD, McCrae KR, Chou WH. Lipocalin-2 released in response to cerebral ischaemia mediates reperfusion injury in mice. J Cell Mol Med. 2015 Jul;19(7):1637-45. doi: 10.1111/jcmm.12538. Epub 2015 Feb 20. PMID:25702801 | PMCID:PMC4511361

Wang L, Davidson DD, Montironi R, Lopez-Beltran A, Zhang S, Williamson SR, MacLennan GT, Wang C, Wang M, Emerson RE, Du X, Cheng L. Small cell carcinoma of the prostate: Molecular basis and clinical implications. Histol Histopathol. 2015 Apr;30(4):413-424. Epub 2014 Nov 10. Review. PMID:25383744

Wang L, Williamson SR, Zhang S, Huang J, Montironi R, Davison DD, Wang M, Yao JL, Lopez-Beltran A, Osunkoya AO, MacLennan GT, Baldridge LA, Du X, Cheng L. Increased androgen receptor gene copy number is associated with TMPRSS2-ERG rearrangement in prostatic small cell carcinoma. Mol Carcinog. 2015 Sep;54(9):900-907. doi: 10.1002/mc.22162. Epub 2014 Apr 29. PMID:24777847

Wang Y, Deng O, Feng Z, Du Z, Xiong X, Lai J, Yang X, Xu M, Wang H, Taylor D, Yan C, Chen C, Difeo A, Ma Z, Zhang J. RNF126 promotes homologous recombination via regulation of E2F1-mediated BRCA1 expression. Oncogene. 2015 Aug 3. doi: 10.1038/onc.2015.198. [Epub ahead of print] PMID:26234677

Ward MC, Bhateja P, Nwizu T, Kmiecik J, Reddy CA, Scharpf J, Lamarre ED, Burkey BB, Greskovich JF, Adelstein DJ, Koyfman SA. The impact of feeding tube choice on severe late dysphagia after definitive chemoradiation for HPV-negative head and neck cancer. Head Neck. 2015 Jun 4. doi: 10.1002/hed.24157. [Epub ahead of print] PMID:26045168

Weiss Wiesel TR, Nelson CJ, Tew WP, Hardt M, Mohile SG, Owusu C, Klepin HD, Gross CP, Gajra A, Lichtman SM, Ramani R, Katheria V, Zavala L, Hurria A; Cancer Aging Research Group (CARG). The relationship between age, anxiety, and depression in older adults with cancer. Psychooncology. 2015 Jun;24(6):712-7. doi: 10.1002/pon.3638. Epub 2014 Aug 6. PMID:25099337 | PMCID:PMC4320028

Wen AM, Infusino M, De Luca A, Kernan DL, Czapar AE, Strangi G, Steinmetz NF. Interface of physics and biology: engineering virus-based nanoparticles for biophotonics. Bioconjug Chem. 2015. 26(1):51-62.

Wienerroither S, Shukla P, Farlik M, Majoros A, Stych B, Vogl C, Cheon H, Stark GR, Strobl B, MÌ_ller M, Decker T. Cooperative Transcriptional Activation of Antimicrobial Genes by STAT and NF-ë¼B Pathways by Concerted Recruitment of the Mediator Complex. Cell Rep. 2015 Jul 14;12(2):300-12. doi: 10.1016/j.celrep.2015.06.021. Epub 2015 Jul 2. PMID:26146080 | PMCID:PMC4521078

William BM, de Lima M. Sirolimus plus calcineurin inhibitors and methotrexate: is more necessarily better? Leuk Lymphoma. 2015 Mar;56(3):555-6. doi: 10.3109/10428194.2014.949262. Epub 2014 Aug 20. No abstract available. PMID:25065702

Wilson RT, Bortner JD Jr, Roff A, Das A, Battaglioli EJ, Richie JP Jr, Barnholtz-Sloan J, Chinchilli VM, Berg A, Liu G, Salzberg AC, El-Bayoumy K. Genetic and environmental influences on plasma vitamin D binding protein concentrations. Transl Res. 2015 Jun;165(6):667-76. doi: 10.1016/j.trsl.2014.08.003. Epub 2014 Aug 27. PMID:25234352

Wuthrick EJ, Zhang Q, Machtay M, Rosenthal DI, Nguyen-Tan PF, Fortin A, Silverman CL, Raben A, Kim HE, Horwitz EM, Read NE, Harris J, Wu Q, Le QT, Gillison ML. Institutional clinical trial accrual volume and survival of patients with head and neck cancer. J Clin Oncol. 2015. 10;33(2):156-64. PMCID:PMC4279235

Xie H, Ahluwalia MS, Peereboom DM. The cleveland clinic experience with primary central nervous system lymphoma. Am J Clin Oncol. 2015 Apr;38(2):140-6. doi: 10.1097/COC.0b013e31828f5a26. PMID:23608829

Xie Q, Wu Q, Horbinski CM, Flavahan WA, Yang K, Zhou W, Dombrowski SM, Huang Z, Fang X, Shi Y, Ferguson AN, Kashatus DF, Bao S, Rich JN. Mitochondrial control by DRP1 in brain tumor initiating cells. Nat Neurosci. 2015 Apr;18(4):501-10. doi: 10.1038/nn.3960. Epub 2015 Mar 2. PMID:25730670 | PMCID:PMC4376639

Xie Q, Wu Q, Mack SC, Yang K, Kim L, Hubert CG, Flavahan WA, Chu C, Bao S, Rich JN. CDC20 maintains tumor initiating cells. Oncotarget. 2015 May 30;6(15):13241-54. PMID:25938542

Yamoah K, Deville C, Vapiwala N, Spangler E, Zeigler-Johnson CM, Malkowicz B, Lee DI, Kattan M, Dicker AP, Rebbeck TR. African American men with low-grade prostate cancer have increased disease recurrence after prostatectomy compared with Caucasian men. Urol Oncol. 2015 Feb;33(2):70.e15-22. doi: 10.1016/j.urolonc.2014.07.005. Epub 2014 Oct 7. PMID:25304288

Yoda A, Adelmant G, Tamburini J, Chapuy B, Shindoh N, Yoda Y, Weigert O, Kopp N, Wu SC, Kim SS, Liu H, Tivey T, Christie AL, Elpek KG, Card J, Gritsman K, Gotlib J, Deininger MW, Makishima H, Turley SJ, Javidi-Sharifi N, Maciejewski JP, et al. Mutations in G protein ¥_ subunits promote transformation and kinase inhibitor resistance. Nat Med. 2015. 21(1):71-5. PMCID:PMC4289115

Yu DC, Patel P, Bonert M, Carlson K, Yilmaz A, Paner G, Magi-Galluzzi C, Lopez-Beltran A, Trpkov K. Urinary bladder xanthoma: a multi-institutional series of 17 cases. Histopathology. 2015 Aug;67(2):255-61. doi: 10.1111/his.12647. Epub 2015 Feb 19. PMID:25580863

Zargar H, Espiritu PN, Fairey AS, Mertens LS, Dinney CP, Mir MC, Krabbe LM, Cookson MS, Jacobsen NE, Gandhi NM, Griffin J, Montgomery JS, Vasdev N, Yu EY, Youssef D, Xylinas E, Campain NJ, Kassouf W, Dall'Era MA, Seah JA, Ercole CE, Horenblas S, et al. Multicenter Assessment of Neoadjuvant Chemotherapy for Muscle-invasive Bladder Cancer. Eur Urol. 2015 Feb;67(2):241-9. doi: 10.1016/j.eururo.2014.09.007. Epub 2014 Sep 23. PMID:25257030

Zeidan AM, Sekeres MA, Wang XF, Al Ali N, Garcia-Manero G, Steensma DP, Roboz G, Barnard J, Padron E, Dezern A, Maciejewski JP, List AF, Komrokji RS; MDS Clinical Research Consortium. Comparing the Prognostic Value of Risk stratifying Models for Patients with Lower-Risk Myelodysplastic Syndromes: Is one model better? Am J Hematol. 2015 Aug 11. doi: 10.1002/ajh.24170. [Epub ahead of print] PMID:26260295

Zhang A, Hitomi M, Bar-Shain N, Dalimov Z, Ellis L, Velpula KK, Fraizer GC, Gourdie RG, Lathia JD. Connexin 43 expression is associated with increased malignancy in prostate cancer cell lines and functions to promote migration. Oncotarget. 2015 May 10;6(13):11640-51. PMID:25960544

Zhang L, Polyansky A, Buck M. Modeling Transmembrane Domain Dimers/Trimers of Plexin Receptors: Implications for Mechanisms of Signal Transmission across the Membrane. PLoS One. 2015;10(4):e0121513. doi: 10.1371/journal.pone.0121513. PMID:25837709 | PMCID:PMC4383379

Zhang M, He J, Liu Z, Lu Y, Zheng Y, Li H, Xu J, Liu H, Qian J, Orlowski RZ, Kwak LW, Yi Q, Yang J. Anti-¥_2-microglobulin monoclonal antibodies overcome bortezomib resistance in multiple myeloma by inhibiting autophagy. Oncotarget. 2015 Mar 31. [Epub ahead of print] PMID:25895124

Zhao B, Yerram NK, Gao T, Dreicer R, Klein EA. Long-term survival of patients with locally advanced prostate cancer managed with neoadjuvant docetaxel and radical prostatectomy. Urol Oncol. 2015 Feb 6. doi:pii: S1078-1439(15)00003-4.  10.1016/j.urolonc.2015.01.001. [Epub ahead of print] PMID:25665510

Zhao S, Sedwick D, Wang Z. Genetic alterations of protein tyrosine phosphatases in human cancers. Oncogene. 2015 Jul 23;34(30):3885-94. doi: 10.1038/onc.2014.326. Epub 2014 Sep 29. Review. PMID:25263441 | PMCID:PMC4377308

Zhao SG, Jackson WC, Kothari V, Schipper MJ, Erho N, Evans JR, Speers C, Hamstra DA, Niknafs YS, Nguyen PL, Schaeffer EM, Ross AE, Den RB, Klein EA, Jenkins RB, Davicioni E, Feng FY. High-throughput transcriptomic analysis nominates proteasomal genes as age-specific biomarkers and therapeutic targets in prostate cancer. Prostate Cancer Prostatic Dis. 2015 May 19. doi: 10.1038/pcan.2015.22. [Epub ahead of print] PMID:25986914

Zhao X, Bodo J, Sun D, Durkin L, Lin J, Smith MR, Hsi ED. Combination of ibrutinib with ABT-199: synergistic effects on proliferation inhibition and apoptosis in mantle cell lymphoma cells through perturbation of BTK, AKT and BCL2 pathways. Br J Haematol. 2015 Mar;168(5):765-8. doi: 10.1111/bjh.13149. Epub 2014 Oct 4. No abstract available. PMID:25284608

Zhao X, Chen-Kiang S, Shetty S, Di Liberto M, Bodo J, Durkin L, Eng K, Elemento O, Smith MR, Hsi ED. CCMCL1: a new model of aggressive mantle cell lymphoma. Blood. 2015 Apr 23;125(17):2730-2. doi: 10.1182/blood-2015-01-622795. No abstract available. PMID:25907904

Zhou W, Ke SQ, Huang Z, Flavahan W, Fang X, Paul J, Wu L, Sloan AE, McLendon RE, Li X, Rich JN, Bao S. Periostin secreted by glioblastoma stem cells recruits M2 tumour-associated macrophages and promotes malignant growth. Nat Cell Biol. 2015. In Press

Zhou Z, Qutaish M, Han Z, Schur RM, Liu Y, Wilson DL, Lu ZR. MRI detection of breast cancer micrometastases with a fibronectin-targeting contrast agent. Nat Commun. 2015 Aug 12;6:7984. doi: 10.1038/ncomms8984. PMID:26264658

Zurita AJ, Khajavi M, Wu HK, Tye L, Huang X, Kulke MH, Lenz HJ, Meropol NJ, Carley W, DePrimo SE, Lin E, Wang X, Harmon CS, Heymach JV. Circulating cytokines and monocyte subpopulations as biomarkers of outcome and biological activity in sunitinib-treated patients with advanced neuroendocrine tumours. Br J Cancer. 2015 Mar 31;112 Suppl:1199-205. doi: 10.1038/bjc.2015.73. PMID:25756398 | PMCID:PMC4385961